Advertisement

Pox-Virus-Krankheiten

  • Günter Stüttgen
Chapter
Part of the Infektionskrankheiten book series (INNEREN)

Zusammenfassung

Die Krankheiten der Pox-Virus-Gruppe zeichnen sich nicht nur durch Gemeinsamkeiten in der Erreger-Struktur (Ruska, H., 1941), sondern auch durch verbindende klinische Merkmale aus.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Variola. Übersichten

  1. Anders, W., u. P.V. Lundt: Praxis der Pockenbekämpfung. Berlin-Heidelberg-New York: Springer 1963.Google Scholar
  2. Dixon, C.W.: Smallpox. London: J. u. A. Churchill 1962.Google Scholar
  3. Ehrengut, W.: Pocken. In: Handbuch der Kinderheilkunde. Berlin-Heidelberg-New York: Springer 1963.Google Scholar
  4. Germer, W.D.: Neuere Erkenntnisse auf dem Gebiete der Pocken. Dtsch. med. Wschr. 76, 1011 (1951).PubMedGoogle Scholar
  5. Die Viruserkrankungen des Menschen. Stuttgart: Georg Thieme 1954.Google Scholar
  6. Herrlich, A.: Die Pocken. Stuttgart: Georg Thieme 1960.Google Scholar
  7. — Handbuch der Schutzimpfungen. Berlin-Heidelberg-New York: Springer 1965.Google Scholar
  8. Höring, F.O.: Pocken (Blattern, Variola). In: Handbuch der inneren Medizin, 4. Aufl., Bd. 1/1. Berlin-Heidelberg-New York: Springer 1951.Google Scholar
  9. Ker, Fl.: Smallpox. Practitioner 187, 283–288 (1961).Google Scholar
  10. Lipschütz, B.: Abschnitt “Vaccine-Variola” im Kapitel “Die Einschlußkrankheiten der Haut”, S. 21–163. In: Handbuch der Haut- u. Geschlechtskrankheiten, hgg. v. J. Jadassohn, Bd. 2, S. 87–93. Berlin: Springer 1932.Google Scholar
  11. Marchionini, A., u. Th. Nasemann: Die Viruskrankheiten der Haut. In: Handbuch der Haut- u. Geschlechtskrankheiten, Ergänzungsband IV/2. Berlin-Heidelberg-New York: Springer 1961.Google Scholar
  12. Morawetz, G.: Akute Exantheme. In: Handbuch der Haut- u. Geschlechtskrankheiten, hgg. v. J. Jadassohn, Bd. XIV, Teil 1, S. 419–458. Berlin: Springer 1930.Google Scholar
  13. Nauck, E.G.: Die Pocken. In: Die Infektionskrankheiten des Menschen und ihre Erreger, Bd. II, S. 1263 (hgg. v. A. Grumbach u. W. Kikuth). Stuttgart: Georg Thieme 1958.Google Scholar
  14. Paschen, E.: Die Pocken. In: Lehrbuch der Infektionskrankheiten, Bd. 2, S. 843–899 (hgg. v. G. Jochmann, bearb. v. C. Hegler). Berlin: Springer 1924.Google Scholar
  15. Schönfeld, W.: Kurze Geschichte der Dermatologie und Venerologie und ihre kulturgeschichtliche Spiegelung. In: Geschichte der Pocken, S. 25/26. Hannover-Kirchrode: Th. Oppermann 1954.Google Scholar
  16. Smadel, J.E.: Smallpox and vaccinia. In: Viral and Rickettsial Infections of Man, ed. 2, pp. 414–439. Philadelphia: Lippincott 1952.Google Scholar
  17. Weber, G.: Die Pocken und die Pockenschutzimpfung. In: Handbuch der Kinderheilkunde, 4. Aufl., Erg., Bd. I, S. 459. Berlin: Springer 1942.Google Scholar

Variola. Erreger

  1. Blank, H., and G. Rake: Viral and rickettsial diseases of the skin, eye and mucous membranes of man. Boston and Toronto: Little, Brown & Comp. 1955.Google Scholar
  2. Blaxall, F.R.: Smallpox. In: A System of Bacteriology in Relation to Medicine, vol. 7, pp. 84–132. London: His Majesty’s Stat. Off. 1930.Google Scholar
  3. Böhls, S.W., and J. V. Irons: Chorio-allantoic membrane infection as a diagnostic test for smallpox. Amer. J. publ. Hlth. 32, 300–306 (1942).Google Scholar
  4. Buddingh, G.J.: Infection of the chorio-allantois of the chick embryo as a diagnostic test for variola. Amer. J. Hyg. 28, 130–137 (1938).Google Scholar
  5. — The pathogenic and antigenic properties of dermal vaccine virus propagated in the chorio-allantois of chick embryos. Amer. J. Hyg. 38, 310–322 (1943).Google Scholar
  6. Burnet, F. M.: Virus as organism: Evolutionary and ecological aspects of some human virus diseases. Cambridge: Harvard University Press 1945.Google Scholar
  7. Downie, A. W., and K. R. Dumbell: The isolation and cultivation of variola virus on the chorio-allantois of chick embryos. J. Path. Bact. 59, 189–198 (1947).PubMedGoogle Scholar
  8. Downie, A. W., and K. R. Dumbell: Pox viruses. Ann. Rev. Microbiol. 10, 237–252 (1956).Google Scholar
  9. Fenner, F., and F.M. Burnet: A short description of the pox-virus group (vaccina and related viruses). Virology 4, 305 (1957).PubMedGoogle Scholar
  10. Hahon, N.: Cytopathogenicity and propagation of variola virus in tissue culture. J. Immunol. 81, 426 (1958).PubMedGoogle Scholar
  11. MacCallum, F.O., and J.R. McDonald: Survival of variola virus in raw cotton. Bull. Org. mond. Santé 16, 247 (1957).Google Scholar
  12. — Effect of temperatures of up to 45° C on survival of variola virus in human material in relation to laboratory diagnosis. Bull. Wld Hlth Org. 16, 441 (1957).Google Scholar
  13. Mahnel, H., and A. Herrlich: On the cultivation of variola and alastrim virus in the incubated chicken egg. Zbl. Bakt., I. Abt. Orig. 181, 137–149 (1961).Google Scholar
  14. Mahnel, H., u. E. Münz: Differenzierung von Variola- und Vakzinevirus in HeLa- und Fl-Zellkulturen. Zbl. Bakt., I. Abt. Orig. 178, 149 (1960).Google Scholar
  15. Mayr, A., u. A. Herrlich: Züchtung des Variolavirus in der infantilen Maus. Arch. Virusforsch. 10, 226 (1961).Google Scholar
  16. Murti, B.R., and J.B. Shrivastav: A study of biological behaviour of variola virus. Indian J. med. Sci. 11, 580 (1957).PubMedGoogle Scholar
  17. Nelson, J.B.: Behaviour of pox viruses in respiratory tract: response of mice to nasal instillation of variola virus. J. exp. Med. 70,107–116 (1939).PubMedCentralPubMedGoogle Scholar
  18. — The stability of variola virus propagated in embryonated eggs. J. exp. Med. 78, 231–239 (1943).PubMedCentralPubMedGoogle Scholar
  19. North, E.A.: A study of the immunological reactions of the variola and vaccinia viruses grown in the developing egg. Aust. J. exp. Biol. med. Sci. 22, 105–109 (1944).Google Scholar
  20. Peters, D., K.H. Andres u. G. Nielsen: Virologische Untersuchungen. Dtsch. med. Wschr. 83, 12 (1958).PubMedGoogle Scholar
  21. Sarkar, J.K., K.N. Neogy, H.P. Chowdhuri, and D. C. Lahiri: Studies of the techniques applicable for characterisation of variola virus. J. Indian med. Ass. 32, 429 (1959).PubMedGoogle Scholar
  22. Schramm, G.: Chemie der Viren. Klin. Wschr. 31, 198 (1953).PubMedGoogle Scholar
  23. Stoeckenius, W., u. D. Peters: Untersuchungen am Virus der Variola-Vaccine. Z. Naturforsch. 10 b, 77 (1955).Google Scholar

Variola. Pathologie und Anatomie

  1. Bras, G.: The morbid anatomy of smallpox. Docum. Med. geogr. trop. (Amst.) 4, 303 (1952).Google Scholar
  2. Councilmann, W. T., G.B. Magrath, and W.R. Brinckerhoff: The pathological anatomy and histology of variola. J. med. Res. 11, 12–135 (1904).Google Scholar
  3. Curschmann, H.: In Handbuch der speciellen Pathologie und Therapie von H. v. Ziemssen, Bd. 2, Theil 2. Leipzig: F.C.W. Vogel 1874.Google Scholar
  4. Kaminura, T.: Pathologisch-anatomische und histologische Studien über Pocken. J. orient. Med. 27, 137 (1937).Google Scholar
  5. Uttley, K.H.: Smallpox mortality in the Negro population of Antigua, West Indiens; a historical note. West Indian Med. J. 9, 169–171 (1960).PubMedGoogle Scholar
  6. Weigert, C.: Anatomische Beiträge zur Lehre von den Pocken. Breslau: M. Cohn & Weigert 1874.Google Scholar
  7. WHO: Die Pockenstatistik 1960 der WHO. Ärztl. Mitt. (Köln) 1961, 1068.Google Scholar

Variola. Pathogenese

  1. Alivisatos, G.P., u. M. Violaki-Paraskeva: Die Virämiedauer nach Vakzination und Variolaerkrankung. Z. Immun.-Forsch. 177, 230 (1959).Google Scholar
  2. Benenson, A.S., C.H. Kempe, and R.E. Wheeler: Problems in maintaining immunity to smallpox. Amer. J. Pub. Health 42, 535–541 (1952).Google Scholar
  3. Collier, W.A.: Hämagglutination durch Pockenvirus. 10. Über Pockenimmunität bei Neugeborenen. Leeuwenhoek med. T. 16, 85 (1950).Google Scholar
  4. Dixon, C.W.: Immunization against smallpox. Brit. J. clin. Pract. 17, 641–648 (1963).PubMedGoogle Scholar
  5. Downie, A.W., K. McCarthy, and A. MaeDonald: Viraemia in small-pox. Lancet 1950 II, 513.Google Scholar
  6. Downie, A. W., T.L. Hobday, St. L. Vincent, and Ch. Kempe: Studies of smallpox antibody levels of sera from samples of the vaccinated adult population of Madras. Bull. Wld Hlth Org. 25, 55–61 (1961).Google Scholar
  7. Hooker, S.B.: A skin test for susceptibility to smallpox; human endermal reactions to killed vaccine virus. J. infect. Dis. 45, 255–262 (1929).Google Scholar
  8. Jadassohn, W.: Abschnitt “Variola u. Vaccine” im Kapitel “Immunbiologie der Haut”, S. 353–478. In: Handbuch der Haut- u. Geschlechtskrankheiten, hgg. von J. Jadassohn, Bd. 2, S. 386–390. Berlin: Springer 1932.Google Scholar
  9. Jenner, E.: An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox (1798). Reprinted by Cassell & Company, Ltd., 1896. Available in Pamphlet Vol. 4232, Army Medical Library, Washington, D.C.Google Scholar
  10. Kämmerer, H.: Über die Lymphotropie der Viruskrankheit Variola. Dtsch. med. Wschr. 80, 655 (1955).PubMedGoogle Scholar
  11. Mastiukova, I.N., et al.: On the mechanism of anti-smallpox immunity. 2. On the role of the leukocytes in anti-smallpox immunity. Analysis of homogenates of the organs of infected animals [russian]. Vop. Virus. 9, 90–95 (1964).Google Scholar
  12. Meiklejohn, G., C.H. Kempe, A.W. Downie, T.O. Berge, L.S. Vincent, and A.R. Rao: Air sampling to recover variola virus in the environment of a smallpox hospital. Bull. Wld Hlth Org. 25, 63 (1961).Google Scholar
  13. Paniker, C.K., and S.L. Kalra: Agar gel diffusion precipitin test in the diagnosis of haemorrhagic smallpox. Indian J. med. Res. 50, 686–689 (1962).Google Scholar
  14. Sarkar, J.K.: Immunity and smallpox. J. Indian med. Ass. 40, 324–326 (1963).PubMedGoogle Scholar
  15. Stickl, H.: Klinische Beobachtungen und experimentelle Untersuchungen zur Pockenimmunität. Arzneimittel-Forschung “Drug Research” 15, 950 (1965).Google Scholar
  16. Waldo, H.H.: Smallpox among “vaccinated” troops. U.S. armed Forces med. J. 6, 799–806 (1955).PubMedGoogle Scholar
  17. Woodville, W.: The History of the Inoculation of the Smallpox in Great Britain, vol. 1, sect. 4, pp. 153–228. London: James Phillips 1796.Google Scholar

Variola. Epidemiologie

  1. Aarsvold, C.M.: Die Pockenepidemie in der Bretagne. T. norske Laegeforen 75, 161 (1955).PubMedGoogle Scholar
  2. Anders, W.: Epidemiologische Besonderheiten der Pockenausbrüche im Nachkriegsdeutschland. Bundesgesundheitsblatt 4, 181 (1961).Google Scholar
  3. Andres, K.H., H. Lieske, H. Lippelt, E. Mannweiler, G. Nielsen, D. Peters u. K. Seelemann: Variola. Klinik, Epidemiologie und Laboratoriumsdiagnostik eines auf dem Luftwege eingeschleppten Falles von Variolois. Dtsch. med. Wschr. 83, 12 (1958).PubMedGoogle Scholar
  4. Barolan, O.V., and A.F. Serenko: Contemporary data on the distribution of smallpox in various countries of the world [russian]. Vop. Virus. 5, 387–396 (1960).Google Scholar
  5. — An outbreak of smallpox in Moscow during 1959–1960 [russian]. Zh. Mikrobiol. 32, 72–79 (1961).Google Scholar
  6. Bedson, H.S., et al.: Variola in Tanganyika. Lancet 1963 II, 1085–1088.Google Scholar
  7. Benenson, A.S.: The continuing threat of smallpox. Arch, environm. Hlth 7, 96–100 (1963).Google Scholar
  8. Bradley, W.H., A. R. Culley, E. C. Benn, H. S. Banks, and J. C. Westwood: Smallpox in England and Wales 1962. Proc. roy. Soc. Med. 56, 335–346 (1963).PubMedGoogle Scholar
  9. Brit. med. J. (Editorial): Smallpox from Karachi. Brit. med. J. 5273, 241–242 (1962).Google Scholar
  10. Cramb, R.: Smallpox outbreak in Brighton, 1950–1951. Publ. Hlth (Lond.) 64, 123–128 (1951).Google Scholar
  11. Creighton, C.: A History of Epidemics in Britain, vol. 2, pp. 434–631. London: Cambridge Univ. Press 1894.Google Scholar
  12. Crosnier, R.: La variole métropolitaine. Enseignements épidémiologiques récents. Sem. Hop. Paris. 1956, 2198.Google Scholar
  13. Daniels, E.: On a legal decision on pox diseases in Heidelberg. Öff. Gesundh.-Dienst 25, 106–107 (1963).Google Scholar
  14. Delas, A., and J. Roguet: Apropos of an epidemic of smallpox in the Northern Cameroons (1961–1962). Méd. Trop. 23,112–124 (1963).Google Scholar
  15. Dekking, F.: Smallpox in Stockholm. Ned. T. Geneesk. 107, 1571–1573 (1963).PubMedGoogle Scholar
  16. Dixon, C.W.: Smallpox in Tripolitania, 1946. An epidemiological and clinical study of 500 cases including trials of penicillin treatment. J. Hyg. 46, 351–377 (1948).PubMedGoogle Scholar
  17. Easton, J.H.L.: An outbreak of smallpox in the Middle East. Publ. Hlth. (Lond.) 58, 110–114 (1945).Google Scholar
  18. Dumjahn, G.: Epidemiological considerations on smallpox hazards in Europe. Dtsch. Gesundh. Wes. 15, 2435–2443 (1960).Google Scholar
  19. Epstein, G.V., M. A. Morozow u. E.V. Exemplarskaya: Wanzen als Überträger von Variolavaccine. G.Batt.Immun. 17, 475 (1936); 1. c. Höring.Google Scholar
  20. Fabre, J.: Smallpox prevalence throughout the World during and after the Second World War. Epidem. vital Statist. Rep. 1, 268–289 (1948).Google Scholar
  21. Falisevac, J.: Certain considerations and observations on the outbreak of the smallpox epidemic in Ceylon in 1958. Lijecn. Vjesn. 82, 839–850 (1960).Google Scholar
  22. Flahault, D., et al.: Various epidemiological and clinical aspects of the smallpox epidemic at Leopoldville (September 1961 to May 1962). Bull. Wld Hlth Org. 29, 117–125 (1963).Google Scholar
  23. Gear, H.S., and Z. Deutschman: Disease Control and International Travel. A review of the International Sanitary Regulations. Smallpox, pp. 27–31. Geneva: Wld Hlth Org. 1956.Google Scholar
  24. Graul, E.: Über das Vorkommen von Blattern in schutzgeimpften Ländern, öff. Gesundh.-Dienst 12, 204 (1950).Google Scholar
  25. Herrlich, A.: Pocken und postvakzinale Enzephalitis. Münch, med. Wschr. 94, 2371, 2433 (1952).Google Scholar
  26. — Probleme der Pocken und Pockenschutzimpfung. Münch, med. Wschr. 96, 529–533 (1954).Google Scholar
  27. — Bericht über die Pockenepidemie in Frankreich. Münch, med. Wschr. 1955, 303.Google Scholar
  28. — Epidemiologie der Pocken. Münch, med. Wschr. 98, 1165 (1956).Google Scholar
  29. — Variola. Eindrücke von einer Epidemie in Bombay im Jahre 1958. Dtsch. med. Wschr. 83, 1426, 1436 (1958).PubMedGoogle Scholar
  30. — Pocken. Klinisches Bild und Erreger. Schriftenreihe aus dem Gebiete des öffentlichen Gesundheitswesens, Heft 11. Stuttgart: Georg Thieme 1960.Google Scholar
  31. Herrlich, A., H.J. Diesfeld u. H. Schmidt: Die Pockenerkrankungen in Ansbach 1961. Dtsch. med. Wschr. 86, 1413 (1961).PubMedGoogle Scholar
  32. Herrlich, C., et al.: Smallpox epidemic in Nordrhein-Westfalen in January 1962. Öff. Gesundh.-Dienst 25,305–312 (1963).Google Scholar
  33. Illingworth, R.S., and W.A. Oliver: Smallpox in the Middle East; lessons from 100 cases. Lancet 1944 II, 681–685.Google Scholar
  34. J. Amer. med. Ass. (Editorial): Smallpox at bay. J. Amer. med. Ass. 183, 54–55 (1963).Google Scholar
  35. Ko Ko, U.: An outbreak of small pox in Kaba Aye area, Insein District, Burma. Burma med. J. 8,144–149 (1960).PubMedGoogle Scholar
  36. Laidlaw, S. I. A., and W. A. Horne: Smallpox outbreak in Glasgow, 1950. M. Officer 83, 187–192 (1950).Google Scholar
  37. Leroux, Amphoux, Billaud, Bouillaud, G. Cadoret, Delord, Duhamel, Lobrichon, Baldrich et Audouy: Epidemie de variola â vannes de décembre 1954Google Scholar
  38. mars 1955. Presse méd. 1955, 639.Google Scholar
  39. McLean, D.M., J.R. Brown, and J.S. Bell: Smallpox in Toronto, 1962. Canad. med. Ass. J. 87, 772–773 (1962.)PubMedGoogle Scholar
  40. Med. J. Aust. (Editorial): Smallpox in England and Wales, 1961–1962. Med. J. Aust. 1, 566–567 (1964).Google Scholar
  41. Millard, C.K.: Smallpox in India. A suggestion. Indian med. Gaz. 86, 209 (1951).Google Scholar
  42. Murray, L.H.: A World review of smallpox incidence. Epidem. vital Statist. Rep. 4, 398–420 (1951).Google Scholar
  43. Nauck, E. G.: Die Bedeutung der Pocken im internationalen Reise-verkehr. Bundesgesundheitsblatt 1958 III, 37.Google Scholar
  44. Report: Smallpox in Europe during the ten last years. Epidem. vital Statist. Rep. 10, 147 (1957).Google Scholar
  45. Rodrigues-da-Silva, G., S.I. Rabello, and J.J. Angulo: Epidemic of variola minor in a suburb of Sao Paulo. 78, 165–171 (1963).Google Scholar
  46. Seymour-Price, M., C. Cachia, and N. R. Fendall: Smallpox in Kenya. E. Afr. med. J. 37,360–365 (1960).Google Scholar
  47. Sivertson, S.E., and J.B. Hyman: Smallpox. Twenty-one cases in United Nations personnel in Korea. U.S. armed Forces med. J. 3, 1777 (1952).PubMedGoogle Scholar
  48. Sword, J.M.: Smallpox in Central Province, Nyassaland. Brit. med. J. 5245, 165–166 (1961).Google Scholar
  49. Stallybrass, C.O.: The Principles of Epidemiology and the Process of Infection, pp. 329, 338. London: Routledge 1931.Google Scholar
  50. Studt, H.: Lehren aus Pockeninfektionen in Nordrhein-Westfalen. Öff. Gesundh.-Dienst 24, 351–370 (1962).Google Scholar
  51. Vincent, L.S., G. Meiklejohn, N.R.. Ratnakannan, A.R. Rao, G.N.V. Krishnan, and C. H. Kempe: Studies on the virus content of mouth washings in the acute phase of smallpox. Bull. Wld Hlth Org. 25, 49 (1961).Google Scholar
  52. WHO Chron.: Smallpox in 1960. WHO Chron. 15, 271–273 (1961).Google Scholar
  53. — Smallpox in 1961. WHO Chron. 16, 419–420 (1962).Google Scholar
  54. — Recent studies in smallpox. WHO Chron. 16, 13–15 (1962).Google Scholar
  55. WHO Expert Committee on Smallpox. First report. WHO Techn. Rep. Ser. 283, 1–37 (1964).Google Scholar

Variola. Klinisches Bild

  1. Baccaredda, A.: Mitigierte Pocken und varioliforme Varicellen in bezug auf eine Gruppe von Fällen, die sich in Genua ereigneten und auf das Zusammentreffen von Syphilis und Pocken. Arch. ital. Derm. 20, 92 (1947).Google Scholar
  2. Eremian, A.V.: Clinical aspects and differential diagnosis of smallpox. On data on an outbreak of transmitted smallpox in Moscow in January, 1960 [russian]. Sovetsk. Med. 25, 40–51 (1961).Google Scholar
  3. Eremian, A.V., A.A. Avakian, and A.P. Romanova: A case of smallpox with a typical course, not diagnosed intra vitally [russian]. Vop. Virus. 7, 597–601 (1962).Google Scholar
  4. Esposito, M. J., and R.C. Ziss: Smallpox. U.S. armed Forces med. J. 3, 677 (1952).PubMedGoogle Scholar
  5. Gray, J.R.: Fever without rash after contact with smallpox. Lancet 1949 I, 749.Google Scholar
  6. Greenberg, M.: Combined staff clinics-Smallpox. Amer. J. Med., 3 355 (1947).Google Scholar
  7. Hammer, B.: Smallpox. Vjschr. Schweiz. Sanitätsoffiz. 40, 111–120 (1963).Google Scholar
  8. Haviland, J.W.: Purpura variolosa. Its manifestations in skin and blood. Yale J. Biol. Med. 24, 518 (1952).PubMedCentralPubMedGoogle Scholar
  9. Herrlich, A.: Guiding clinical symptoms in smallpox. A short summary of its most important signs. Arch. Hyg. Bakt. 147, 305–306 (1963).PubMedGoogle Scholar
  10. Jeliffe, D. B.: Congenital cataract and maternal smallpox. J. trop. Med. Hyg. 55, 99 (1952).Google Scholar
  11. Keevill, A. J.: A little-known complication of smallpox in Tanganyika. E. Afr. Med. J. 37, 692 (1960).Google Scholar
  12. Lynch, F.W.: Dermatologie conditions of the foetus with particular reference to variola and vaccinia. Arch. Derm. Syph. (Chic.) 26, 997–1019 (1932).Google Scholar
  13. Marcolongo, F., u. U. Careassi: Pocken- und Herz-Kreislaufsystem. Zbl. ges. Kinderheilk. 69,161 (1959).Google Scholar
  14. Mikhail, I.K.: Late deformities due to destructive osteoarticular lesions in small-pox. J. Med. Liban. 16, 3–16 (1963).PubMedGoogle Scholar
  15. Murphy, E.F.: Variola major: a clinical review of seventeen cases. Med. Offr. 91, 139 (1954).Google Scholar
  16. Narayana Rao, Y.S., N.R. Ratnakannan, K.S. Balasubramaniam, and K.N. Scri-Gopolan: Smallpox in a child aged 3 days. Brit. med. J. 1954, 1459.Google Scholar
  17. Paranjothy, D., and I. Samuel: Pregnancy associated with haemorrhagic smallpox. J. Obstet. Gynaec. Brit. Emp. 67, 309–313 (1960).PubMedGoogle Scholar
  18. Pescatore, S.: On varioliform gastritis. Rass. int. Clin. Ter. 43, 1221–1229 (1963).PubMedGoogle Scholar
  19. Rabello, S.I., J.J. Angulo, and J. Sesso: Simultaneous vaccinia and variola in an eczematous infant Arch. Derm. Syph. (Chic.) 85, 405–406 (1962).Google Scholar
  20. Ramachandra, Rao A., I. Prahlad, and M. Swaminathan: A study of 1,000 cases of smallpox. J. Indian med. Ass. 35, 296–307 (1960).Google Scholar
  21. Rao, A. R., I. Prahlad, M. Swaminathan, and A. Lakshmi: Pregnancy and smallpox. J. Indian med. Ass. 40, 353–363 (1963).PubMedGoogle Scholar
  22. Sweitzer, S.E., and K. Ikeda: Variola; a clinical study of the Minneapolis epidemic of 1924–1925. Arch. Derm. Syph. (Chic.) 15, 19–29 (1927).Google Scholar
  23. Stüttgen, G.: Zur Klinik der Pocken. Internist (Berl.) 4, 429–435 (1963).Google Scholar
  24. Thanawala, J.K.: Smallpox in children. Indian J. Pediat. 23, 153 (1956).PubMedGoogle Scholar
  25. Wolman, M.: Pathologie findings in hemorrhagic smallpox (Purpura variolosa). Report of a case, with special reference to Feulgen’s reaction in tissue. Amer. J. clin. Path. 21, 1127 (1951).Google Scholar

Variola. Diagnose

  1. Anderson, T., M.A. Foulis, N.R. Grist, and J.B. Landsman: Clinical and laboratory observations in a smallpox outbreak. Lancet 1951 I, 1248.Google Scholar
  2. Bingel, K.F., u. F. Kruse: Methoden und Ergebnisse der virologischen und serologischen Untersuchungen bei den Pockenerkrankungen in Heidelberg. Medizinische 1959, Nr. 20, 961.Google Scholar
  3. Blawat, F., et al.: Laboratory diagnosis of smallpox at the Institute of Marine Medicine in Gdansk during the 1963 epidemic. Bull. Inst. mar. trop. med. Gdansk 15, 23–28 (1964).Google Scholar
  4. Collier, W. A., A.M. Smit, and A.F. van Heerde: Der Nachweis von Antihämagglutininen bei Variolapatienten als diagnostisches Hilfsmittel. Z. Hyg. Infekt.-Kr. 131, 555–567 (1950).Google Scholar
  5. Craigie, J., and F.O. Wishart: The complement-fixation reaction in variola. Canad. J. publ. Hlth 27, 371–379 (1936a).Google Scholar
  6. — Studies on the soluble precipitable substances of vaccinia. II. The soluble precipitable substances of dermal filtrate. J. exp. Med. 64, 819–830 (1936b).PubMedCentralPubMedGoogle Scholar
  7. Deodhar, N.S.: The status of the microscopic diagnosis in the epidemiology of smallpox. Indian J. med. Sci. 15, 517–528 (1961).PubMedGoogle Scholar
  8. — The status of the microscopic diagnosis in the epidemiology of smallpox. Indian J. med. Sci. 15, 517 (1961).PubMedGoogle Scholar
  9. Deodhar, N.S., and P.M. Dongre: Smallpox within nine months of primary vaccination. Indian med. J. (1960).Google Scholar
  10. Downie, A. W., and A. MacDonald: A study of the pox viruses by complementfixation and inhibition of complement fixation methods. J. Path. Bact. 62, 389–401 (1950).PubMedGoogle Scholar
  11. — Smallpox and related virus infections of man. Brit. med. Bull. 9, 191 to 195 (1953).PubMedGoogle Scholar
  12. Downie, A. W., K. McCarthy, A. MacDonald, F.O. McCallum, and A.D. Macrae: Virus and virus antigen in the blood of smallpox patients. Their significance in early diagnosis and prognosis. Lancet 1953 II, 164–166.Google Scholar
  13. Fiorillo, A.M., and C.L. Campana: Electrophoretic pattern of the serum proteins and C-reactive protein in smallpox. Rev. Inst. Med. trop. S. Paulo 3, 85–90 (1961).PubMedGoogle Scholar
  14. Herzberg, K., D. Lang, R. Dahn u. K. Reuss: Über die Präparation von virushaltigem Untersuchungsmaterial für diagnostische, speziell elektronenmikroskopische Untersuchungen. Zbl. Bakt., I. Abt. Orig. 194, 3 19–331 (1964).Google Scholar
  15. Kaiser, M.: Die Pocken- schnelldiagnose nach Tièche. Leuwenhoek ned. T. 16, 97 (1950).Google Scholar
  16. — Eine Schnelldiagnose der Pocken. Z. Tropenmed. Parasit. 3, 230 (1951).Google Scholar
  17. — Bemerkungen zum vorstehenden Aufsatz von Prof. Yaol. Klin. Med. 11, 65 (1956).Google Scholar
  18. Kirsh, D.: The use of immunofluorescence in the rapid presumptive diagnosis of variola. Bull. Wld Hlth Org. 29, 126–128 (1963).Google Scholar
  19. Kompanejez, A., S. Dmitrieff u. S. Nikolskaja: Die Agglutinationsreaktion bei Pocken. Z. Mikrobiol. 14, 159 (1935).Google Scholar
  20. Kühn, O.: Erleichterungen beim Nachweis des Pockenvirus im mikroskopischen Präparat. Zbl. Bakt., I. Abt. Orig. 168, 480 (1957).Google Scholar
  21. Lépine, P., et O. Croissant: Application de Ia microscopie électrique au diagnostic de Ia variole. Presse méd. 1952, 1427.Google Scholar
  22. MacCallum, F.O.: Early diagnosis of smallpox. In: The Dynamics of Virus and Rickettsial Infections, pp. 324–333. New York: Blakiston, 1954.Google Scholar
  23. MacCallum, F.O., C.A. McPherson, and D.F. Johnstone: Laboratory investigation of smallpox patients with particular reference to infectivity in the early stages. Lancet 1950 II, 514–517.Google Scholar
  24. Murray, H.G.: The diagnosis of smallpox by immunofluorescence. Lancet 1963 I, 847–848.Google Scholar
  25. Nagler, F.P.O., and G. Rake: The use of the electron microscope in diagnosis of variola, vaccinia and varicella. J. Bact. 55, 45 (1948).PubMedGoogle Scholar
  26. Peters, D., G. Nielsen, and M.E. Bayer: Variola. Reliability of the rapid electron-microscopic diagnosis. Dtsch. med. Wschr. 87, 2240–2246 (1962).PubMedGoogle Scholar
  27. Pöhn, H.P.: Mikrobiologie und Epidemiologie der Variola. Internist (Berl.) 4,435–441 (1963).Google Scholar
  28. Ricketts, T.F., and J.B. Byles: The Diagnosis of Smallpox. 154 pp. London: Cassell 1908.Google Scholar
  29. Rooyen, C.E. van, and R.S. Illingworth: A laboratory test for diagnosis of smallpox. Brit. med. J. 2, 526–529 (1944).PubMedGoogle Scholar
  30. Rooyen, C.E. van, and G.D. Scott: Smallpox diagnosis with special reference to electron microscopy. Canad. J. publ. Hlth. 39, 467 (1948).Google Scholar
  31. Salchow, U.A.: Über diagnostische Möglichkeiten bei Infektionen mit einem Virus aus der Variola-Vaccina-Gruppe. Arch. Hyg. (Berl.) 139,608 (1955).Google Scholar
  32. Tièche, M.: Über die mit der cutanen Allergiemethode gewonnenen diagnostischen Resultate während der Pockenepidemie 1921 bis 1923. Schweiz, med. Wschr. 1924, 361.Google Scholar

Variola. Therapie

  1. Cheville, N.F., R.G. Marshall, R.J. Janssen, and P.J. Gerone: The effect of 6-mercaptopurine on variola infections in rhesus monkeys. II. Hematological studies. J. infect. Dis. 111, 163–166 (1962).PubMedGoogle Scholar
  2. Dally, A.: New drug for smallpox tried out in Madras. Indian med. J. 58, 56 (1964).PubMedGoogle Scholar
  3. Bauer, D. J., K.R. Dumbell, P. Fox-Hulme, and P.W. Sadler: The chemotherapy of variola major infection. Bull. Wld Hlth Org. 26, 727–732 (1962).Google Scholar
  4. Bauer, D.J., et al.: Prophylactic treatment of smallpox contacts with N-Methylisatin Beta-Thiosemicarbazone (compound 33T57, Marboran). Lancet 1963 II, 494–496.Google Scholar
  5. Bauer, D. J., P.W. Sadler: New antiviral chemotherapeutic agent active against smallpox infection. Lancet 1960 1, 1110–1111.PubMedGoogle Scholar
  6. Berke, Z.: Pockenbekämpfung in Afghanistan. Zbl. Bakt., I. Abt. Orig. 165, 301 (1956).Google Scholar
  7. Breen, G.E.: Antibiotics in smallpox. Lancet 1951 II, 713.Google Scholar
  8. Hobday, T.L.: Antivaccinial gamma-globulin in the control of smallpox. Lancet 1962 I, 907–908.Google Scholar
  9. Horsfall, F.L., and I. Tamm: Chemotherapy of viral and rickettsial diseases. Ann. Rev. Microbiol. 11, 339–370 (1957).Google Scholar
  10. Kempe, C.H., T.O. Berge, and B. England: Hyperimmune vaccinal gamma globulin. Source, evaluation and use in prophylaxis and therapy. Pediatrics 18, 177–188 (1956).PubMedGoogle Scholar
  11. Kempe, C.H., C. Bowles, G. Meiklejohn, T.O. Berge, L. St. Vincent, B. V. Babu, S. Govindarajan, N.R. Ratnakannan, A.W. Downie, and V.R. Murthy: The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox. Bull. Wld Hlth Org. 25, 41–48 (1961).Google Scholar
  12. Marsden, J.P., and W.J. Coughlan: Antibiotics in smallpox. Lancet 1951 II, 711.Google Scholar
  13. Marennikova, S.S.: The use of hyperimmune antivaccinia gamma-globulin for the prevention and treatment of smallpox. Bull. Wld Hlth Org. 27, 325–330 (1962).Google Scholar
  14. Muraoka, M., A. Takada, and T. Ueda: Antiviral effect of alkylpyrimidine derivatives. Keio J. Med. 11,95–103 (1962).PubMedGoogle Scholar
  15. Peirce, E.R., F.S. Melville, A.W. Downie, and M.J. Duckworth: Antivaccinial gamma-globulin in smallpox prophylaxis. Lancet 1958 II, 635.Google Scholar
  16. Peterson, O.P., et al.: Antiviral effect of interferon [russian]. Vop. Virus. 8, 719–724 (1963).Google Scholar
  17. Shapma, R.: Osteomyelitis variolosa during corticosteroid therapy. J. Indian med. Ass. 41, 202–204 (1963).Google Scholar
  18. Santosh, K. de: Serumtreatment of smalpox. J. Indian med. Ass. 5, 670 (1936).Google Scholar
  19. Stickl, H.: Zur Therapie der Pocken. Dtsch. med. Wschr. 1966, 455–457.Google Scholar
  20. Stolte, J.B., and G. J. Sas: Chloramphenicol and ACTH in smallpox. Lancet 1951 II, 715.Google Scholar

Alastrim

  1. Angulo, J.J.: Variola minor in a primary school. Publ. Hlth. Rep. (Wash.) 79, 355–365 (1964).Google Scholar
  2. Blomhert, G.: Klinische ervaringen van alastrim te’s Gravenhage. Ned. T. Geneesk. 99, 681 (1955).PubMedGoogle Scholar
  3. — Clinical experiences with alastrim. Docum. Med. geogr. trop. (Amst.) 8, 197 (1956).Google Scholar
  4. Breuseghem, L. van: Transmission au lapin et â la souris blanche d’un virus isolé â Stanleyville au cours d’une épidémie d’alastrim. Ann. Soc. beige Méd. trop. 20, 383 (1940).Google Scholar
  5. Briceno Rossi, A. L.: The differences in alastrim virus. Bol. Ofic. sanit. panamer. 54, 419–423 (1963).PubMedGoogle Scholar
  6. Copeman, S.M.: The relationship of small-pox and alastrim. Ann. Rep. Minist. Hlth. London for 1919–1920. App. II. 1920.Google Scholar
  7. Dinger, J.E.: The concept of “Alastrim”. Docum. Med. geogr. trop. (Amst.) 7, 108 (1955); 8, 202 (1956).Google Scholar
  8. — Difference in persistence of smallpox and alastrim virus on the chorioallantois. Docum. Med. geog. trop. Amst. 8, 202–206 (1956).Google Scholar
  9. Downie, A.W., K.R. Dumbell, P.A. Ayroza Galvao, and I. Zatz: Alastrim in Brazil. Acta leidensia 32, 75–79 (1963).Google Scholar
  10. Downie, A. W., and A. MacDonald: Smallpox and related virus infections in man. Brit. med. Bull. 9, 191 (1953).PubMedGoogle Scholar
  11. Downie, A. W., K. McCarthy, and A. MacDonald: Laboratory methods in the diagnosis of alastrim. Mth. Bull. Minist. Hlth Lab. Serv. 1952 II, 227.Google Scholar
  12. Dubois, A.: Variola et Alastrim. Rev. méd. Liège 2,281 (1947).PubMedGoogle Scholar
  13. Dumbell, K.R., H.S. Bedson, and E. Rossier: The laboratory differentiation between variola major and variola minor. Bull. Wld Hlth Org. 25, 73 (1961).Google Scholar
  14. Garcia, A. G.: Fetal infection in chickenpox and alastrim, with histopathologic study of the placenta. Pediatrics 32, 895–901 (1963).PubMedGoogle Scholar
  15. Helbert, D.: Smallpox and alastrim. Use of the chick embryo to distinguish between the viruses of variola major and variola minor. Lancet 1957, 1012.Google Scholar
  16. Innes, J.: Variola minor in Rochdale and district, 1951–1952. Publ. Hlth. (Lond.) 66, 136 (1953).Google Scholar
  17. de Jong, M.: Alastrim, een ziekte sui generis. Acta leidensia 25, 145 (1955).Google Scholar
  18. — The alastrim epidemic in The Hague 1953–1954. Docum. Med. geog. trop. (Amst.) 8, 207–235 (1956).Google Scholar
  19. Kröber, F.: Beobachtung einer Epidemie von Alastrim. Dtsch. med. Wschr. 1934, 793.Google Scholar
  20. MacCallum, W.G., and L.M. Moody: Alastrim in Jamaica. Amer. J. Hyg. 1, 388 (1921).Google Scholar
  21. McCarthy, K., and A.W. Downie: The serum antibody response in alastrim. Lancet 1953 I, 257 to 260.Google Scholar
  22. Marsden, J. P.: Loss of immunity against vaccinia after attack of variola minor. Brit. 793.Google Scholar
  23. Mahnel, H., u. A. Herrlich: Zur Züchtung des Variola- und Alastrimvirus im bebrüteten Hühnerei. Zbl. Bakt., I. Abt. Orig. 181, 137 (1961).Google Scholar
  24. Malamos, B.: Tropical diseases in Brazil. Trans, roy. Soc. trop. Med. Hyg. 43, 11 (1949).Google Scholar
  25. Marsden, J.P.: Loss of immunity against vaccinia after attack of variola minor. Brit. Med. J. 1964, 5410, 676.Google Scholar
  26. — Variola minor. A personal analysis of 13,686 cases. Bull. Hyg. (Lond.) 23, 735–746 (1948).Google Scholar
  27. Marsden, J.P., and W.J. Coughlan: Variola minor. Mth. Bull. Minist, Hlth. Lab. Serv. 11, 74 (1952).Google Scholar
  28. Moody, L.M.: Some notes on alastrim. Proc. Int. Congr. on Health Problems in Tropical America. Kingston, B.W.I., p. 760. Boston: United Fruit Co. 1924.Google Scholar
  29. Moran, L.M., and D. Kolm: Schoenlein-Henoch purpura and alastrim. Dia méd. 32, 2517–2521 (1960).PubMedGoogle Scholar
  30. Nizamuddin, M.D., and K.R. Dumbell: A simple laboratory test to distinguish the virus of smallpox from that of alastrim. Lancet 1961 1, 68.PubMedGoogle Scholar
  31. Polano, M.K.: Over de histologic van de alastrim blaar in vergelijking met andere bij Virusziekten voorkomende blaren. Arch, beiges Derm. 13, 321 (1957).Google Scholar
  32. Rossi, C.M., e. H.C. Tosi: Cultivo del virus del alastrim. Arch. urug. Med. 30, 91.Google Scholar
  33. Seaffidijr, V., e. A. Silvano: Sulla indificatione con l’alastrim di una malattia erutiva riscontrata tragli indigeni dell’Eritrea. Arch. ital. Sci. med. colon. 18, 351 (1937).Google Scholar
  34. Tiller, R.: Zur Ätiologie, Epidemiologie, Klinik und Diagnostik der Alastrim. Diss. München 1960.Google Scholar
  35. Torres, C.M.: Further studies on the pathology of alastrim and their significance in the variolaalastrim problem. Proc. roy. Soc. Med. 29, 1525–1539 (1935–1936).PubMedGoogle Scholar
  36. Torres, C.M., et J. de C. Teixeira: Alterations de l’épidemie dans la rougeole. Inclusions intranucléaires dans Ies cellules du “stratum granulosum” et des couches superficielles du corps muqueux de Malpighi. C.R. Soc. Biol. (Paris) 109, 138 (1932).Google Scholar
  37. — Estudo comparativo das inclusoes do alastrim e da variola vera. Mem. Inst. Osw. Cruz 30, 183 (1935).Google Scholar

Kuhpocken

  1. Berger, K.: Infektionsversuche mit dem Virus des Melkerknotens. Zbl. Bakt., I. Abt. 162, 363–372 (1955).Google Scholar
  2. — Kuhpocken virus und Vaccine virus. Z. Hyg. Infekt.-Kr. 143, 151–158 (1956).Google Scholar
  3. Berger, K., u. F. Puntigam: Experimentelle Kuhpockeninfektion beim Rind. Zbl. Bakt., I. Abt. Orig. 172, 363 (1958).Google Scholar
  4. Boulter, E.A., J.C.N. Westwood, and H.B. Maber: Value of serotherapy in a virus disease (rabbit pox). Lancet 1961 II, 7210, 1012.Google Scholar
  5. Burnet, F.M., and J.D. Stone: The haemagglutinins of vaccinia and ectromelia viruses. Australian J. exp. med. Sci. 24, 1–8 (1946).Google Scholar
  6. Datt, N.S.: Comparative studies of pigpox and vaccinia viruses. I. Host range pathogenicity. J. comp. Path. 74, 62–69 (1964).Google Scholar
  7. — Comparative studies of pigpox and vaccinia viruses. II. Serological relationship. J. comp. Path. 74, 70–80 (1964).PubMedGoogle Scholar
  8. Dawson, I.M., and A.S. McFarlane: Structure of an animal virus. Nature (Lond.) 161,464–466.Google Scholar
  9. Dekking, F.: Koepokken en vaccinia. T. Diergueneesk. 75, 248–250 (1950).Google Scholar
  10. — Personal communication, 1955.Google Scholar
  11. Dosch, F., u. H. Moritsch: Virologische Untersuchungen im Zusammenhang mit einer Laboratoriumsinfektion durch Kuhpockenvirus. Zbl. Bakt., I. Abt. Orig. 166, 517 (1956).Google Scholar
  12. Downie, A.W.: A study of the lesions produced experimentally by cowpox virus. J. Path. Bact. 48, 361–379 (1939a).Google Scholar
  13. — The immunological relationship of the virus of spontaneous cowpox to vaccinia virus. Brit. J. exp. Path. 20, 158–176 (1939b).Google Scholar
  14. Downie, A.W., and K. McCarthy: The viruses of variola, vaccinia, cowpox and ectromelia. Neutralization tests on the chorio-allantois with unabsorbed and absorbed immune sera. Brit. J. exp. Path. 31, 789–796 (1950).PubMedGoogle Scholar
  15. Downie, A. W., and D.W. Haddock: A variant of cow-pox virus. Lancet 1952, 1049.Google Scholar
  16. Dumbell, K.R., A.W. Downie, and R.C. Valentine: The ratio of the number of virus particles to infective titer of cowpox and vaccinia virus suspension. Virology 4, 467–482 (1957).PubMedGoogle Scholar
  17. Erichsen, S.: The inhibition of the proliferation of cowpox virus in embryonated hens eggs by cortisone. I. Study by measurement of the thickness of the proliferated ectoderm in infected chorioallantoic membranes. Acta endocr. (Kbh.) 43, 439–446 (1963).Google Scholar
  18. — The inhibition of the proliferation of cowpox virus in embryonated hens’ eggs by cortisone. II. Titration of pock forming units in infected chorioallantoic membranes. Acta endocr. (Kbh.) 43, 447–457 (1963).Google Scholar
  19. Fenner, F.: The biological characters of several strains of vaccinia, cowpox and rabbitpox viruses. Virology 5, 502 (1958).PubMedGoogle Scholar
  20. Gipsen, R.: Analysis of pox-virus-antigens by means of double diffusion. A method for direct serological differentiation of cow-pox. J. Immunol. 74,134 (1955).Google Scholar
  21. Hagan, W. A., and D.W. Bruner: Infections diseases of domestic animals, p. 726. London: Baillière, Tindall & Cox 1957.Google Scholar
  22. Halbrohr, J.G.: Observations on 5 human cases of infection by bovine pox virus (cowpox). Arch, venez. Pat. trop. 3, 136–158 (1959).Google Scholar
  23. Herrlich, A., u. A. Mayr: Vergleichende experimentelle Arbeiten über die “Vaccine-Kuhpocken-Viren”. Arch. Hyg. (Berl.) 138, 479 (1954).Google Scholar
  24. — Die Differenzierung der Tierpockenviren im bebrüteten Hühnerei. Arch. Hyg. (Berl.) 139, 444 (1955).Google Scholar
  25. Hester, H. R., L. E. Boley, and R. Graham: Studies on cowpox. 1. An outbreak of natural cowpox and its relation to vaccinia. Cornell Vet. 31,360–378 (1941).Google Scholar
  26. J. Amer. med. Ass. (Editorial): Cowpox and smallpox. J. Amer. med. Ass. 177, 446–447 (1961).Google Scholar
  27. Kato, S.: Diagnosis of smallpox and cowpox by the fluorescent antibody technic. Clin. All Round (Osaka) 13,1239–1247 (1964).Google Scholar
  28. Lan, H. J., S.M. Cheng, and W.E. Ching: A case report of horsepox. Zhong Waike Z. 10, 51 (1962).Google Scholar
  29. Leroy, D., J. Bizais, M.E. Richier-Chevrel, et J.L. Richier: Une épidémie humain de cowpox en Bretagne. Sem. Hop. Paris 1953, 1182.Google Scholar
  30. Mayr, A.: Experimentelle Arbeiten über das hämagglutinierende Prinzip bei den Tierpocken viren. Arch. ges. Virusforsch. 6, 439 (1956).PubMedGoogle Scholar
  31. Mayr, A., A. Herrlich u. H. Mahnel: Experimentelle Untersuchungen über das S-Antigen bei den Tierpockenviren. Arch. Hyg. (Berl.) 139, 580 (1955).Google Scholar
  32. Maqsood, M.: Generalised Buffalo-pox. Vet. Ree. 70, 321 (1958).Google Scholar
  33. Moritsch, H.: Experimentelle Untersuchungen über die Vermehrung des Vaccinia- und des Kuhpockenvirus in der Maus. Zbl. Bakt., I. Abt. Orig. 166, 427 (1956).Google Scholar
  34. — Virulenz und Pathogenität des Kuhpocken virus. Z. Tropenmed. Parasit. 8, 333 (1957).Google Scholar
  35. — Experimentelle Untersuchungen über Anreicherungsversuche des Kuhpockenvirus im Gehirn der Maus. Zbl. Bakt., I. Abt. Orig. 168, 165 (1957).Google Scholar
  36. Peters, D.: Morphologie und Biochemie tierpathogener Virusarten. Verh. dtsch. path. Ges. 38. Tagg., S. 14, 1954.Google Scholar
  37. — Struktur und Entwicklung der Pockenviren: 4. Int. Kongr. Elektronenmikroskopie, S. 552. Berlin-Heidelberg-New York: Springer 1958.Google Scholar
  38. Takahashi, M., S. Kameyama, and J. Kamahora: A study on the morphological and cytoimmunological relationship between the inclusions of variola, cowpox, rabbitpox, vaccinia (variola origin) and vaccinia IHD and a consideration of the term “Guarnieri body”. Biken’s J. 2, 353 (1959).Google Scholar
  39. Tongeren, H. A.E. van: Spontaneous mutation of cowpox virus by means of eggpassage. Arch. ges. Virusforsch. 5, 35 (1952).Google Scholar
  40. Verlinde, J.D.: Koepokken bij de meus. T. Diergeneesk. 76, 334 (1951).Google Scholar
  41. Viazhevich, V.K.: On certain characteristics of human and bovine smallpox. Zh. Mikrobiol. (Mosk.) 32, 149 (1961).Google Scholar
  42. — Some features of cowpox in man. Zh. Mikrobiol. (Mosk.) 32, 770–771 (1961).Google Scholar
  43. Wirth, D., u. K. Diernhofer: Lehrbuch der inneren Krankheiten der Haustiere. Stuttgart: Ferdinand Enke 1950.Google Scholar
  44. Wittels, S.W.: Kuhpockeninfektion. Falldemonstration: Österr. Derm. Ges. 7. III. 1957.Google Scholar
  45. Wittels, S.W.: Hautarzt 9, 277 (1958).Google Scholar
  46. Wittels, S.W.: Derm. Wschr. 137, 265 (1958).Google Scholar

Melkerknoten

  1. Beck, J.R.: Milker’s nodules: A clinical note. Delaware med. J. 12, 180 (1940).Google Scholar
  2. Becker, F.T.: Milker’s nodules. J. Amer. med. Ass. 115, 2140 (1940).Google Scholar
  3. Berger, K.: Infektionsversuche mit dem Virus des Melkerknotens. Zbl. Bakt., I. Abt. Orig. 162, 363 (1955).Google Scholar
  4. Bonnevie, P.: Melkerknoten. Ugeskr. Laeg. 1935, 143.Google Scholar
  5. — Ref. Zbl. Haut- u. Geschl.-Kr. 50, 689 (1935).Google Scholar
  6. — Milker’s warts: infection from “false cowpox” with a paravaccinia virus. Brit. J. Derm. 49, 164 (1937).Google Scholar
  7. Bosse, K.: Untersuchungen über Paravaccine bei Mensch und Haustieren. Diss. München 1957.Google Scholar
  8. Brants, J.: Über einen Fall von Melkerknoten. Arch. Derm. Syph. (Berl.) 178, 87 (1938).Google Scholar
  9. Campanella, P.: Su un caso di noduli dei mungitori. Minerva derm. 32, 61.Google Scholar
  10. Carteaud, A.: Dermatoses professionelles des campagnes. Rev. Prat. 5,455 (1955).PubMedGoogle Scholar
  11. Cawley, E.P., C.W. Withmore, and C.E. Wheeler: Milker’s nodules. Sth. med. J. (Bgham, Ala.) 46, 21 (1953).Google Scholar
  12. Christen, P.: Vaccinationsversuche gegen die Euterpocken des Rindes und ein Beitrag zu deren Diagnostik. Schweiz. Arch. Tierheilk. 81, 53 (1939).Google Scholar
  13. Danbolt, N.: “Melkerknoten”, eine paravaccinale Übertragung von “Kuhpocken” auf Menschen. T. norske Laegeforen. 69, 177 (1949).Google Scholar
  14. Danbolt, N.: Ref. Zbl. Haut- u. Geschl.-Kr. 73, 326 (1949).Google Scholar
  15. Dolgov, A., u. M. Morosow: Zur Frage der Ätiologie der Melkerknoten. Sovetsk. Vestn. Derm. 9, 338 (1931).Google Scholar
  16. — Ätiologie des Melkerknotens. Gig. i. Epidem. 10, 71 (1931).Google Scholar
  17. — Ref. Zbl. ges. Hyg. 27, 443 (1931).Google Scholar
  18. Duncan, A. G.: Milker’s nodules. Canad. med. Ass. J. 77, 339 (1957).PubMedGoogle Scholar
  19. Epstein, St.: Milker’s nodules of the noses resembling granuloma pyogenicum. Arch. Derm. Syph. (Chic.) 78, 391.Google Scholar
  20. Falchi, G.: Rilievi clinici e ricerche sperimentali sui noduli vaccinali. G. ital. Derm. Sif. 77, 181 (1936).Google Scholar
  21. Faquelle, R., P. de Graciansky, S. Boulle, J. Dalion, et P. Agasse: Tubercule (ou nodule) des trayeurs. Bull. Soc. fran9. Derm. Syph. 58, 481 (1951).Google Scholar
  22. Findlay, G.H., and D.A. Haig: Milker’s nodules. Growth of the virus in developing hen eggs. Brit. J. Derm. 64, 451 (1952).PubMedGoogle Scholar
  23. Frieboes, V.: Über Melkerknoten. Verh. 9. intern. Kongr. Derm. 2, 435 (1936).Google Scholar
  24. Gans, O.: Histologie der Hautkrankheiten, Bd. 2, S. 35. Berlin: Springer 1928.Google Scholar
  25. Garrison Jr., S.C., and C.E. Adams: Milker’s nodules. J. Tenn. med. Ass. 46, 420 (1953).PubMedGoogle Scholar
  26. Gay-Prieto, J., J. Cazorla u. M. Rodriguez: Über Melkerknoten bei Ziegenmelkern. Act. dermosifiliogr. (Madr.) 27, 631 (1935).Google Scholar
  27. Gay-Prieto, J., J. Cazorla u. M. Rodriguez: Ref. Zbl. Haut- u. Geschl.-Kr. 50, 575 (1935).Google Scholar
  28. Gottron, H.: Beitrag zur Ätiologie der Melkerknoten. Derm. Z. 58, 207 (1930).Google Scholar
  29. Green, M.T.: Milker’s nodules. New Orleans med. surg. J. 97, 13 (1944).Google Scholar
  30. Greither, A., u. H. Tritsch: Die Geschwülste der Haut. Stuttgart: Georg Thieme 1957.Google Scholar
  31. Groth, A.: Zur Ätiologie der Melkerknoten. Münch, med. Wschr. 1929, 2128.Google Scholar
  32. Grüneberg, Th., u. A. Heinig: “Melkerknoten” nach Infektion mit dem Virus der Stomatitis papulosa der Rinder. Arch. klin. exp. Derm. 205, 144 (1957).PubMedGoogle Scholar
  33. Henry, A., et L. Bory: Les vaccinoides ou nodosités dites des trayeurs (â propos un cas observé chez un vétérinaire). Bull. Soc. frang. Derm. Svph. 41, 1884 (1934).Google Scholar
  34. Herzberg, K.: Über Viruskrankheiten in der Dermatologie. Arch. Derm. Syph. (Berl.) 188, 526 (1949).Google Scholar
  35. Horacek, J.: On so-called paronychia in milk maids (Peiser’s disease). Pracov. Lék. 13, 421–423 (1961).PubMedGoogle Scholar
  36. Hudelo, L., et R. Rabut: Les tubercules des trayeurs. Paris méd. 1931, 55.Google Scholar
  37. Jadassohn, W., and R. Paillard: Microbids caused by para vaccine. Dermatologica (Basel) 122, 52–54 (1961).Google Scholar
  38. Joppe, I.: “Melkerknoten”? Ned. T. Geneesk. 78, 2767 (1934).Google Scholar
  39. Kaiser, M.: Vaccina und Para vaccina. Wien. klin. Wschr. 1949, 783.Google Scholar
  40. — Der Ablaufder Pockenschutzimpfung, seine Abweichungen und Komplikationen. In: Theorie und Praxis der Pockenschutzimpfung, Sonderbd. 5 der Sammlung “Immunität, Allergie u. Infektionskrankheiten”, S. 109–113. München: Verlag der Ärztl. Rundschau, Otto Gmelin 1949.Google Scholar
  41. — Die Melkerknoten als Problem. Wien. klin. WTschr. 1952, 669.Google Scholar
  42. Kaiser, M., u. M. Cherardini: Studien über Melkerknoten. Arch. Derm. Syph. (Berl.) 169, 77 (1933).Google Scholar
  43. Kaiser, M., u. F. Winfurther: Kuhpocken und vaccinale Melkererkrankung. Z. Hyg. Infekt.-Kr. 113, 192 (1931).Google Scholar
  44. Katzenellenbogen, I.: Beitrag zur Ätiologie der Melkerknoten. Acta derm.-venereol. (Stockh.) 16, 316 (1935).Google Scholar
  45. — Studies on milker’s nodules. Dermatologica (Basel) 105, 69 (1952).Google Scholar
  46. Kuske, H., u. W. Soltermann: Melkerknoten auf Versuchspersonen mit positivem Resultat überimpft. Dermatologica (Basel) 116, 385 (1958).Google Scholar
  47. Laurance, B.: Cowpox in man and its relationship with milker’s nodules. Lancet 1955, 764.Google Scholar
  48. Lehmann, E.: Zum Krankheitsbild der Melkerknoten. Zbl. Chir. 57, 1529 (1930).Google Scholar
  49. Liedberg, N.: Spezifische Fingerinfektion des Menschen: Melkerknoten. Nord. Med. 1942, 549.Google Scholar
  50. Liedberg, N.: Ref. Zbl. Haut- u. Geschl.-Kr. 70, 182 (1943).Google Scholar
  51. Lipschütz, B.: Unter suchungen über die Ätiologie der Paravakzine. Zbl. Bakt., I. Abt. Orig. 81, 105 (1918).Google Scholar
  52. — Untersuchungen über Paravaccine. Arch. Derm. Syph. (Berl.) 127, 193 (1919).Google Scholar
  53. — Über sekundäre Para vaccine. Derm. Wschr. 1921, 879.Google Scholar
  54. — Paravaccine. In: Handbuch der Haut- u. Geschlechtskrankheiten, hgg. von J. Jadassohn, Bd. 2, S. 80–84. Berlin: Springer 1932.Google Scholar
  55. Ludwig, A.: Über Melkerknoten am Oberlid. Arch. Augenheilk. 109, 346 (1935).Google Scholar
  56. Lutz, W.: Melkerpocken. Dermatologica (Basel) 110, 370 (1955).Google Scholar
  57. Mahnke, P.F.: Zur Pathologie und Ätiologie der Melkerknoten. Zbl. allg. Path. Anat. 100, 128 (1959).Google Scholar
  58. Maire, G., Fr. Woringer, et J. Houot: Eruption vaccinale professionelle des mains consécutive a une inoculation de cow-pox (tubercule vaccinal du trayeur). Bull. Soc. frang. Derm. Syph. 39, 892 (1932).Google Scholar
  59. Marchionini, A., u. Th. Nasemann: Zur Diagnostik der durch Viren der Pockengruppe hervor-gerufenen Erkrankungen des Menschen. Arch. klin. exp. Derm. 202, 69 (1955).PubMedGoogle Scholar
  60. Martinotti, L.: Considerazioni sui noduli dei mungitori. Dermosifilografo 25, Suppl., 145 (1951).Google Scholar
  61. May, J.: Zum Studium der durch Melken erworbenen Krankheiten. Rev. argent. Dermatosif. 21, 329 (1937).Google Scholar
  62. Nageli, H.: Über das Vorkommen von Melkerknoten und ihre günstige Beeinflussung durch Sulfonamidverbindungen. Dtsch. Mil.-Arzt 6, 428 (1941).Google Scholar
  63. Nageli, H.: Ref. Zbl. Haut- u. Geschl.-Kr. 68, 72 (1942).Google Scholar
  64. Nasemann, Th.: Biologie, Morphologie und andere Eigenschaften des Paravaccinevirus. Vortrag: 6. Tagg. der Österr. Ges. für Mikrobiol. u. Hyg. 24.-27. II. 1958. Ref. Zbl. Bakt., I. Abt. Ref. 169, 352 (1958).Google Scholar
  65. — Bemerkungen zu der Arbeit von K. zum Winkel: Beobachtungen an Melkerknoten. Derm. Wschr. 1959, 188.Google Scholar
  66. Nasemann, Th., u. E. Bauer: Elektronenoptische Untersuchungen am Paravaccinevirus (v. Pirquet). Klin. Wschr. 35, 62 (1957).PubMedGoogle Scholar
  67. Nasemann, Th., u. B. Deubner: Beitrag zur Virusätiologie des Melkerknotens. Hautarzt 4, 210 (1953).PubMedGoogle Scholar
  68. Nomland, R., and A.P. McKee: Milker’s nodules. Report often cases. Arch. Derm. Syph. (Chic.) 65, 663 (1952).Google Scholar
  69. Nusshag, W.: Vaccine-Infektion bei einem Melker. Tierärztl. Umsch. 1936, 187.Google Scholar
  70. Ormea, F., and W. Argano: Milker’s nodule with staphylococcal superinfection. Minerva derm. 36, 183–184 (1961).PubMedGoogle Scholar
  71. Petracek, E.: Beitrag zur Ätiologie der Melkerknoten. Derm. Z. 71, 71 (1935).Google Scholar
  72. Petrin, S.: Über Melkerknoten. Med. Klin. 1941, 351.Google Scholar
  73. Pierini, L.E., D. Grinspan, y D. Ugazio: Nodulos de los ordenadores. Arch, argent. Derm. 2, 111 (1952).Google Scholar
  74. Pierini, L.E., D. Grinspan, y D. Ugazio: Ref. Zbl. Haut- u. Geschl.-Kr. 84, 48 (1953).Google Scholar
  75. Pirquet, Cl. v.: Die Paravaccine. Z. Kinderheilk. 13, 309 (1915).Google Scholar
  76. Platt, H.: The significance for man of some dermotropic virus infections of animals. Med. Press 1958, 1195.Google Scholar
  77. Pomuss, B.J.: Über Melkerknoten. Derm. Wschr. 1934, 134.Google Scholar
  78. Puntigam, F., u. E. Orth: Ein Beitrag zur Ätiologie der Melkerknoten. Wien. klin. Wschr. 1951, 540.Google Scholar
  79. Reczko, E.: Elektronenmikroskopische Untersuchungen am Virus der Stomatitis papulosa. Zbl. Bakt., I. Abt. Orig. 169, 425 (1957).Google Scholar
  80. Richter, R., u. M. Kressmann: Beobachtungen über das Vorkommen und die Symptomatologie der Melkerknoten. Arch. Derm. Syph. (Berl.) 192, 245 (1950).Google Scholar
  81. Richter, R., u. L. Tat: “Melkerknoten” als Schafpockenerkrankung in der Türkei. Derm. Wschr. 1954, 370.Google Scholar
  82. Riehl, G.: Melkerknoten. Zbl. Haut- u. Geschl.-Kr. 81, 116 (1952).Google Scholar
  83. Ruska, H., u. G. A. Rausch: Über Form, Größenverteilung und Struktur einiger Viruselementarkörper. Zbl. Bakt., I. Abt. Orig. 150, 311 (1943).Google Scholar
  84. Salkan, P.M.: Zur Klinik der Epidemiologie und Ätiologie der Melkerknoten. Acta derm.- venereol. (Stockh.) 14, 342 (1933).Google Scholar
  85. Schultze, W., u. Fr. v. Grundherr: Über Melkerknoten mit toxischem Exanthem. Arch. Derm. Syph. (Berl.) 158, 1 (1929).Google Scholar
  86. Schultze, W., O. Seifried u. J. Schaaf: Die Melkerknoten und ihre Ätiologie. Z. Infekt.-Kr. Haustiere 31, 295 (1927).Google Scholar
  87. Sedlacek, V., u. J. Kunz: Melkerknoten. Prakt. Lék. (Praha) 35, 303 (1955).Google Scholar
  88. Sedlacek, V., u. J. Kunz: Ref. Excerpta med. (Amst.), Sect. XIII 10, 287 (1956).Google Scholar
  89. Senin, A.: Beitrag zur Kenntnis der sog. Melkerknoten. Derm. Wschr. 1932, 605.Google Scholar
  90. Shdanow, W.M.: Viren bei Mensch und Tier. Evolution, Systematik und Bestimmung, S. 56, 160 u. 164. Jena: Gustav Fischer 1957.Google Scholar
  91. Sonck, C.E.: Milker’s nodules with allergic secondary eruptions. Acta allerg. (Kbh.) 4, 241 (1951).Google Scholar
  92. Sonck, C.E., and K. Penttinen: Milker’s nodules transmission from man to man. Acta derm.-venereol. (Stockh.) 34, 420 (1954).Google Scholar
  93. Stark, A.M., M.M. Tiesenhausen, N.M. Goschanskaja, E.W. Skrotzky, D.S. Schtschastny u. W.A. Zuk: Über die Pockenätiologie der sog. Melkerknoten. Arch. Derm. Syph. (Berl.) 170, 38 (1934).Google Scholar
  94. Tappeiner, J.: Zur Frage der vaccinalen Ätiologie der Melkerknoten. Wien. klin. Wschr. 1938, 1061.Google Scholar
  95. Truffi, G.: Melkerknoten. Arch. 9. intern. Kongr. Derm. 1, 361 (1935).Google Scholar
  96. Varca, C.: Über die Melkerknoten. Dermosifilografo 11, 192 (1936).Google Scholar
  97. Varca, C.: Ref. Zbl. Haut- u. Geschl.-Kr. 54, 528 (1937).Google Scholar
  98. Wagner, V., A. Tomsikova, V. Vilim u. J. Zdaril: Anteil der Torulastämme an der Ätiologie der Melkerknoten. Zbl. Bakt., I. Abt. Orig. 173, 260 (1958).Google Scholar
  99. Wallace, H.J.: A note on milker’s nodes. Brit. J. Derm. 59, 379 (1947).Google Scholar
  100. Wendelberger, J.: Über zwei Fälle von Melkerknoten. Derm. Wschr. 1933, 1199.Google Scholar
  101. Wheeler, C.E., and E.P. Cawley: Milker’s nodules. Sth. med. J. (Bgham, Ala.) 49, 973 (1956).Google Scholar
  102. — The etiology of milker’s nodules. A.M.A. Arch. Derm. 75, 249 (1957).Google Scholar
  103. Winkel, K. zum: Beobachtungen an Melkerknoten. Derm. Wschr. 1958, 293.Google Scholar
  104. Winternitz, R.: Knotenbildungen bei Melkerinnen. Arch. Derm. Syph. (Berl.) 49, 195 (1899).Google Scholar
  105. Woringer, Fr.: Deux nouveaux cas de tubercules du trayeur. Bull. Soc. frang. Derm. Syph. 41, 197 (1934).Google Scholar
  106. Zeitlin, I.: Über die Ätiologie der Melkerinnenknötchen. Sovet. Vestn. Vener. i. Derm. 3, 602 (1934).Google Scholar
  107. Zeitlin, I.: Ref. Zbl. Haut- u. Geschl.-Kr. 49, 693 (1935).Google Scholar
  108. Zumbusch, L. v.: Über Melkerknoten. Arch. Derm. Syph. (Berl.) 150, 311 (1926).Google Scholar
  109. Zurukzoglu, St., u. E. Kuske: Beitrag zum Problem der Ätiologie der Melkerknoten. Acta derm.-venereol. (Stockh.) 19, 569 (1938).Google Scholar

Vaccinia

  1. Almeida Ganzalves, J. C.: Malignant Change in Smallpox Vaccination Scars. Arch. Derm. 93, 229 (1966).Google Scholar
  2. Bachmann, K.D.: Über das parainfektiöse Enzephalitis-Syndrom im Kindesalter. Fortschr. Med. 81,354 (1963).Google Scholar
  3. Baldridge, G.D., and A.M. Kligman: The relationship between hypersensitivity and immunity to vaccinia. J. invest. Derm. 18,205 (1952).PubMedGoogle Scholar
  4. Bauer, D. J.: The antiviral and synergic actions of Isatin Thiosemicarbazone and certain Phenoxypyrimidines in vaccinia infection in mice. Brit. J. exp. Path. 36, 105–114 (1955).PubMedGoogle Scholar
  5. Berger, K.: Todesfälle nach Pockenschutzimpfung. Wien. med. Wschr. 144, 249 (1964).Google Scholar
  6. Bigler, J.A., and E.L. Slotkowski: Smallpox vaccination with prolonged vaccinia. Pediatrics 7, 24–33 (1951).PubMedGoogle Scholar
  7. Briody, B. A.: A unitarian view of vaccinia hemagglutinin. Yale J. Biol. Med. 24, 1–4 (1951).PubMedCentralPubMedGoogle Scholar
  8. Broom, J.C.: Revaccination in adults. Lancet 1947 I, 364–366.Google Scholar
  9. Bugbee, L.M., A.A. Like, and R.B. Stewart: The effects of cortisone on intradermally induced vaccinia infection in rabbits. J. infect. Dis. 106, 166–173 (1960).PubMedGoogle Scholar
  10. Browne, S.G., and E.M. Davis: Reaction in leprosy precipitated by smallpox vaccination. Leprosy Rev. 33, 252–254 (1962).PubMedGoogle Scholar
  11. Chu, C.M.: Studies on vaccinia haemagglutinin. I. Some physiochemical properties. J. Hyg. 46, 42–48 (1948).PubMedGoogle Scholar
  12. Cocchi, P.: Antiviral activity of 4-aminopteroylglutamic acid on vaccinia virus in tissue cultures. Antibiot. and Chemother. 11, 79–88 (1961).Google Scholar
  13. Cochran, W., and J.H. Connolly: Bone involvement after vaccination against smallpox. Brit. med. J. 1963, 5352, 285–287.Google Scholar
  14. Collier, L.H.: The development of a stable smallpox vaccine. J. Hyg. 53, 76–101 (1955).PubMedGoogle Scholar
  15. Collier, L.H., D. McClean, and L. Vallet: The antigenicity of ultraviolet irradiated vaccinia virus. J. Hyg. 53, 513–534 (1955).PubMedGoogle Scholar
  16. O’Connell, C. J., et al.: Progressive vaccinia with normal antibodies. A case possibly due to deficient cellular immunity. Ann. intern. Med. 60, 282–289 (1964).PubMedGoogle Scholar
  17. Cook, E.B.M., B. Bell, P. Forsyth, J.V. Irons, and G.W. Cox: Use of chorio-allantoic membrane culture smallpox vaccine in Texas. Tex. Rep. Biol. Med. 11, 522–529 (1953).PubMedGoogle Scholar
  18. Craigie, J.: The nature of the vaccinia flocculation reaction, and observations on the element-ary bodies of vaccinia. Brit. J. exp. Path. 13, 259–268 (1932).Google Scholar
  19. Craigie, J., and F. O. Wishart: Skin sensitivity to the elementary bodies of vaccinia. Canad. J. publ. Hlth. 24, 72 (1933).Google Scholar
  20. Downie, A. W.: The immunological relationship of the virus of spontaneous cow-pox to vaccinia virus. Brit. J. exp. Path. 20, 158 (1939).Google Scholar
  21. Easterbrook, K.B., and C.I. Davern: The effect of 5-bromodeoxyuridine on the multiplication of vaccinia virus. Virology 19, 509–520 (1963).Google Scholar
  22. Elford, W.J., and C.H. Andrewes: Filtration of vaccinia virus through gradocol membranes. Brit. J. exp. Path. 13,36–42 (1932).Google Scholar
  23. Finlay-Jones, L.R.: Fatal Myocarditis after vaccination against smallpox. Report of a case. New Engl. J. Med. 270, 41–42 (1964).Google Scholar
  24. Flewett, T.H., and F.L. Ker: A case of vaccinia necrosum (or progressive vaccinia), with severe hypogamma- globulinaemia, treated with n-methyl isatin beta-thiosemicarbazone (33T57). J. clin. Path. 16, 271–277 (1963).PubMedGoogle Scholar
  25. Gillen, A.L., M.M. Burr, and F.P. Nagler: Recovery of two distinct hemagglutinins of vaccinia virus. J. Immunol. 65, 701–706 (1950).PubMedGoogle Scholar
  26. Goetzeler, A.: Tödlicher Ausgang eines Falles von Ekzemevaccination. Münch, med. Wschr. 102,1419–1422 (1960).Google Scholar
  27. Greenberg, M.: Complications of vaccination against smallpox. Amer. J. Dis. Child. 76, 492–502 (1948).Google Scholar
  28. Hall, G.F.M., A.C. Cunliffe, and J.A. Dudgeon: Prolonged generalized vaccinia. J. Path. Bact. 66, 25–38 (1953).PubMedGoogle Scholar
  29. Hamre, D., K.A. Brownlee, and R. Donovick: Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones. J. Immunol. 67, 305–312 (1951).PubMedGoogle Scholar
  30. Herrlich, A.: Welchen Nutzen hat die Prophylaxe der postvakzinalen Enzephalitis. Eine vergleichende Bewertung der heutigen Methoden. Dtsch. med. Wschr. 89, 968–974 (1964).PubMedGoogle Scholar
  31. Herrlich, A., u. A. Mayr: Vergleichende experimentelle Arbeiten über die “Vaccine-Kuhpocken-Viren”. Arch. Hyg. (Berl.) 138, 479 (1954).Google Scholar
  32. Herrlich, A., A. Mayr, H. Mahnel u. E. Münz: Experimentelle Studien über die Transformation des Variola- in das Vaccine-Virus. Arch. ges. Virusforsch. 12, 579–599 (1963).Google Scholar
  33. Herrlich, A., H. Stickl u. E. Münz: Kann man den Ablauf der Pockenschutzimpfung medikamentös beeinflussen. Dtsch. med. Wschr. 90, 69 (1965).PubMedGoogle Scholar
  34. Herrlich, A., H. Aldinger u. H. Möbest: Morphologische und serologische Bewertung der Reaktion auf die Wiederimpfung gegen Pocken unter besonderer Berücksichtigung der virusneutralisierenden Antikörper. Dtsch. med. Wschr. 90, 2225–2229 (1965).PubMedGoogle Scholar
  35. Herzberg, K.: Vergleichende Vaccinevirusunter- suchungen. Zbl. Bakt., I. Abt. Orig. 162, 408–430 (1955).Google Scholar
  36. Herzberg, K.: Die Technik der Färbung von Elementarkörpern des Variola- und Vaccinia-Virus mit Victoria-Blau. Zbl. Bakt., I. Abt. Orig. 177, 145–148 (1960).Google Scholar
  37. Holden, M., and L.B. Adams: The influence of hydrocortisone on vaccinia virus grown in L cells. J. infect. Dis. 110, 268–277 (1962).PubMedGoogle Scholar
  38. Hood, C.K., and E. McKinnon: Prenatal vaccinia. Amer. J. Obstet. Gynec. 85, 238–240 (1963).PubMedGoogle Scholar
  39. Hyatt, W., sr.: Unusual responses to smallpox vaccinations in two children. 1. Lymphatic transfer of smallpox vaccine from deltoid area, with resultant primary takes in two new sites (wrist and finger), in a 23-week-old male infant. 2. Abundant hair growth, around periphery of recently healed smallpox scar, in a one-year-old female infant. Pediatrics 32, 288–290 (1963).Google Scholar
  40. Joppich, I.: Verhalten und klinische Signifikanz der Vaccine-Hämagglutinations-Hemm- körper im 1. Lebensmonat. Mschr. Kinderheilk. III, 138–140 (1963).Google Scholar
  41. Kanellopulos, N.P., K. Ioannu u. I. Antoniadis: Ein Fall einer thrombopenischen Purpura nach Pockenimpfung. Med. Klin. 57, 1816–1817 (1962).PubMedGoogle Scholar
  42. Kaplan, C.: The antigenicity of y-irradiated vaccinia virus. J. Hyg. (Lond.) 58, 391–398 (1960).Google Scholar
  43. Kaufman, H.E., A.B. Nesburn, and E.D. Maloney: Cure of vaccinia infection by 5-iodo-2’-deoxyuridine. Virology 18, 567–569 (1962).PubMedGoogle Scholar
  44. Keidan, S.E., K. McCarthy, and J.C. Haworth: Fatal generalized vaccinia with failure of anti-body production and absence of serum gamma globulin. Arch. Dis. Childh. 28, 110–116 (1953).PubMedGoogle Scholar
  45. Killpack, W.S.: Prenatal vaccinia. Lancet 1963 I, 388.Google Scholar
  46. Kozinn, P. J., M.M. Sigel, and R. Gorrie: Progressive vaccinia associated with agammaglobulinemia and defects in immune mechanism. Pediatrics 16, 600 (1955).PubMedGoogle Scholar
  47. Kozlowska, J., and L. Sztymela: Generalized haemorrhagic vaccinia during remission of acute leukaemia. Arch. Dis. Childh. 37, 442–443.Google Scholar
  48. Landsman, J.B., et al.: Controlled trial of marboran on group vaccinated against smallpox. Lancet 1964 I, 330.Google Scholar
  49. Lea, D.E., and M.H. Salaman: The inactivation of vaccinia virus by radiations. Brit. J. exp. Path. 23, 27–37 (1942).Google Scholar
  50. Lebedev, V.N.: A case of hemorrhagic vasculitis following smallpox vaccination. Klin. Med. (Mosk.) 41, 142–143 (1963).Google Scholar
  51. Lindenmann, J., and G.E. Gifford: Studies on vaccinia virus plaque formation and its inhibition by interferon. I. Dynamics of plaque formation by vaccinia virus. Virology 19, 283–293.Google Scholar
  52. — Studies on vaccinia virus plaque formation and its inhibition by interferon. III. A simplified plaque inhibition assay of interferon. Virology 19, 302–309 (1963).PubMedGoogle Scholar
  53. Lewis, H.M., and F.C. Johnson: Fatal agammaglobulinemic progressive vaccinia. Report of a case with a classification of human cutaneous vaccinia. A.M.A. Arch. Dermat. 75, 837–844 (1957).Google Scholar
  54. Lyon, E.: Pockenimpfung und Cortisonbehandlung. Dtsch. med. Wschr. 10,401–403 (1959).Google Scholar
  55. Macadam, D.B., and W. Whitaker: Cardiac complications after vaccination for smallpox. Brit, med. J. 1962, 5312, 1099–1100.Google Scholar
  56. Marquardt, J., R. Geister u. D. Peters: Präparation und Eigenschaften hoch gereinigter Vaccine-Virus-Suspensionen. Arch. ges. Virusforsch. 12, 561–578 (1963).Google Scholar
  57. Mastiukova, N.Iu., and N.V. Iaroslavskaia: On antismalJpox antibodies [russian]. Vop. Virus. 7, 67–72 (1961).Google Scholar
  58. Marmelzat, W.L., et al.: Malignant melanomas in smallpox vaccination scars. Report of six cases. Arch. Derm. (Chic.) 89, 823–826 (1964).Google Scholar
  59. McCrea, J.F., J. W. Preiss, and J. 0’Loughlin: Physical studies on pox viruses. I. Inactivation of vaccinia virus infectivity with low-energy electrons. Biophys. J. 1, 43–53 (1960).PubMedCentralPubMedGoogle Scholar
  60. Meindersma, T.E.: Thrombocytopenia after vaccination against smallpox. Ned. milit. geneesk. T. 14, 199–205 (1961).PubMedGoogle Scholar
  61. Megay, K.: Cutan-allergische Reaktionen mit Antigenen aus der Vaccine-Variola-Gruppe. Wien. klin. Wschr. 1950, 404.Google Scholar
  62. Nagler, F.P.O.: Application of Hirst’s phenomenon to the titration of vaccinia virus and vaccinia immune serum. Med. J. Aust. 1, 281–283 (1942).Google Scholar
  63. Naidoo, P., and H. Hirsch: Prenatal vaccinia. Lancet 1963 1, 196–197.PubMedGoogle Scholar
  64. Nanning, W.: Prophylactic effect of antivaccinia gamma-globulin against postvaccinal encephalitis. Bull. Wld Hlth Org. 27, 317–324 (1962).Google Scholar
  65. Overman, J.R., and I. Tamm: Equivalence between vaccinia particles counted by electron microscopy and infectious units of the virus. Proc. Soc. exp. Biol. Med. 92, 806–810 (1956).PubMedGoogle Scholar
  66. — Multiplication of vaccinia virus in the chorio-allantoic membrane in vitro. Virology 3, 173–184 (1957).PubMedGoogle Scholar
  67. Palacios, R., G. Contreras, R. Espejo, R. Jimenez, A. Ohlbaum, and A. Toha: Compound survival curve of vaccinia-virus after gamma radiation. Biochim. biophys. Acta (Amst.) 68, 149–151 (1963).Google Scholar
  68. Parker, R.F., and T.M. Rivers: Immunological and chemical investigations of vaccine virus. IV. Statistical studies of elementary bodies in relation to infection and agglutination. J. exp. Med. 64, 439–452 (1936a).PubMedCentralPubMedGoogle Scholar
  69. — Immunological and chemical investigations of vaccina virus. III. Response of rabbits to inactive elementary bodies of vaccinia and to virus-free extracts of vaccine virus. J. exp. Med. 63, 69–94 (1936b).PubMedCentralPubMedGoogle Scholar
  70. Paschen, E.: Vaccine und Vaccineaus- schläge. In: Handbuch der Haut- u. Geschlechtskrankheiten, hgg. von J. Jadassohn, Bd. II, S. 251–258. Berlin: Springer 1932.Google Scholar
  71. Patoria, N.K.: Hemagglutination studies of variola and vaccinia viruses. Indian J. med. Sci. 17, 871–875 (1963).PubMedGoogle Scholar
  72. Peters, D., and W. Stoeckenius: Untersuchungen am Virus der Variola-Vaccine. III. Mitt.: Enzymatischer Abbau des Innenkörpers. Z. Naturforsch. 9b, 524–529 (1954).Google Scholar
  73. Pincus, W.B., and J.A. Flick: The role of hypersensitivity in the pathogenesis of vaccinia virus infection in humans. J. Pediat. 62, 57–62 (1963).PubMedGoogle Scholar
  74. Rada, B., Z. Budesinsky, and Z. Perina: Inhibition of vaccinia virus multiplication by 2-carboxymethylmercapto-4-amino-5-(p-chlorphenyl)-pyrimidine. Experientia (Basel) 19, 196–197 (1963).Google Scholar
  75. Raettig, H.: Aktive Immunisierung heute und morgen. Wien. med. Wschr. 113, 366–370 (1963).PubMedGoogle Scholar
  76. Rohwedder, H. J., et al.: Nephrotisches Syndrom nach Pockenimpfung. Arch. Kinderheilk. 168, 53–60 (1963).PubMedGoogle Scholar
  77. Rooyen, C.E. van, and A.J. Rhodes: The variola-vaccinia virus: animal experiments. In: Virus Diseases of Man, pp. 308–333. New York: Nelson 1948.Google Scholar
  78. Rosen, F.S., et al.: Dangers of vaccination in lymphopenic infants. Pediatrics 33, 310–311 (1964).PubMedGoogle Scholar
  79. Salaman, M.H.: The combining properties of vaccinia virus with the antibodies demonstrable in anti-vaccinial serum. Brit. J. exp. Path. 18, 245–258 (1937).Google Scholar
  80. Schafer, K.H.: Nierenerkrankung nach Pockenimpfung. Mschr. Kinderheilk. 111, 361–368 (1963).Google Scholar
  81. Scheiffarth, F.: Vaccination von Allergikern. Med. Welt (Berl.) 45, 2386 bis 2391 (1962).Google Scholar
  82. Siegert, R., u. W. Schulz: Über den Beginn und die Dauer der Virämie nach Pockenschutzimpfung. Z. Hyg. Infekt.-Kr. 137, 81 (1953).Google Scholar
  83. Smadel, J.E., T.M. Rivers, and L. Hoagland: Nucleoprotein antigen of vaccine virus. I. A new antigen obtained from elementary bodies of vaccinia. Arch. Path. 34, 275–285 (1942).Google Scholar
  84. Smadel, J.E., T.M. Rivers, and E.G. Pickels: Estimation of the purity of preparations of elementary bodies of vaccinia. J. exp. Med. 70, 379–385 (1939).PubMedCentralPubMedGoogle Scholar
  85. Smejkal, F., and F. Sorm: The effect of 6-azauracil riboside against vaccinia virus in rabbits. Acta virol. 6, 282 (1962).PubMedGoogle Scholar
  86. Spillane, J.D., et al.: The neurology of jennerian vaccination. A clinical account of the neurological complications which occurred during the smallpox epidemic in South Wales in 1962. Brain 87, 1–44 (1963).Google Scholar
  87. Stickl, H., u. J. Engelhardt: Die Gewebeimmunität nach der Pockenschutzimpfung und ihr Nachweis mit Hilfe der Immuncytolyse: Ausarbeitung eines Mikrotestes für die Praxis. Münch, med. Wschr. 106, 2302 (1964).Google Scholar
  88. — Die Leukocytolyse als Zeichen der spezifischen Reaktionsfähigkeit der Gewebe auf Vaccinevirus nach der Pockenschutzimpfung. Klinische, experimentelle und elektronenmikroskopische Untersuchungen. Z. ges. Hyg. 1965 (im Druck).Google Scholar
  89. Stoeckenius, W., and D. Peters: Untersuchungen am Virus der Variola-Vaccine. IV. Mitt.: Die Morphologie des “Innenkörpers”. Z. Naturforsch. 10b, 77–80 (1955).Google Scholar
  90. Stuart, G.: Memorandum on post-vaccinal encephalitis. Bull. Wld Hlth Org. 1, 36–53 (1947–1948).Google Scholar
  91. Tamm, I., and J.R. Overman: Relationship between structure of benzimidazole derivatives and inhibitory activity on vaccinia virus multiplication. Virology 3, 185–196 (1957).PubMedGoogle Scholar
  92. Thompson, E.L., M. Price, S.A. Minton jr., E.A. Falco, and G.H. Hitchings: Protection of mice against the vaccinia virus by the administration of phenoxythiouracils. J. Immunol. 67, 483–491 (1951).PubMedGoogle Scholar
  93. Türk, E.: Klinik und Praxis der subkutanen Pockenschutzimpfung. Wien. med. Wschr. 101, 774 (1951).PubMedGoogle Scholar
  94. — Pockenschutzimpfung kutan oder subkutan? Öst. Z. Kinderheilk. 10, 322 (1954).Google Scholar
  95. Vignes, P.: Is smallpox vaccination of pregnant women harmful for the embryo and the fetus? Maternité 12, 186–196 (1963).PubMedGoogle Scholar
  96. Vladimirskaia, E.B.: Complications in leukemic patients vaccinated against smallpox. Sovetsk. Med. 25, 118–120 (1961).Google Scholar
  97. Weber, G., u. J. Lange: Zur Variationsbreite der “Inkubationszeiten” postvakzinaler zerebraler Erkrankungen. Dtsch. med. Wschr. 31, 1461 (1961).Google Scholar
  98. Webster, I.M.: The response of leprosy patients to smallpox vaccine. W. Afr. med. J. 8, 322 to 324 (1959).PubMedGoogle Scholar
  99. White, C.M.: Vaccinia gangrenosa due to hypogammaglobulinaemia. Lancet 1963 I, 969–971.Google Scholar
  100. Wilson, E.: Radiation inactivation of vaccinia virus. Radiat. Res. 14, 796–802 (1961).PubMedGoogle Scholar
  101. Wohlrab, R.: Die Pockenschutzimpfung. In: Schutzimpfungen, hgg. von H. Spieß, S. 172–204. Stuttgart: Georg Thieme 1958.Google Scholar
  102. Yaol, H.: Über die subkutane Pockenschutzimpfung. Steht die subkutane Schutzimpfung in ihrem Erfolg der kutanen wesentlich nach? Klin. Med. 11, 49 (1956).Google Scholar

Molluscum contagiosum

  1. Appelmans, M., J. Michiels, and L. Jamotton: Pseudochalazion durch Molluscum contagiosum. Bull. soc. beige Ophthal. 125, 1018–1028 (1960).Google Scholar
  2. Banfield, W.G.: Dense granule in the elementary body of molluscum contagiosum. J. biophys. biochem. Cytol. 5, 513 (1959).PubMedCentralPubMedGoogle Scholar
  3. Banfield, W.G., and D.C. Brindley: An electron microscopic study of the epidermal lesion of molluscum contagiosum. Ann. N.Y. Acad. Sci. 81, 145–163 (1959).PubMedGoogle Scholar
  4. Baran, L.R.: Evolution paradoxale d’une éruption profuse de Molluscum contagiosum traitée par érythromycine puis par terramycine. Bull. Soc. fran9. Derm. Syph. 65, 343 (1958).Google Scholar
  5. Blank, H.: Virus induced tumors of human skin (warts, molluscum contagiosum). Ann. N.Y. Acad. Sci. 54, 1226 (1952).PubMedGoogle Scholar
  6. Blank, H., and G. Rake: Viral and rickettsial diseases of the skin, eqe and mucous membranes of man. Boston and Toronto: Little, Brwon & Comp. 1955.Google Scholar
  7. Carteaud, A.J.P.: L’inoculabilité â l’homme du “Molluscum contagiosum” et des verrues. Auto-observations. Bull. Soc. fran9. Derm. Syph. 65, 260 (1958).Google Scholar
  8. Cassazza, R.: Eine noch nicht beschriebene Abart des Molluscum contagiosum (Molluscum contagiosum cornoides). Derm. Wschr. 1934, 260.Google Scholar
  9. Chang, T.W., and L. Weinstein: Cytopathic agents isolated from lesions of molluscum conta-giosum. J. invest. Derm. 37, 433–439 (1961).PubMedGoogle Scholar
  10. Craps, M.: Eruption profuse de molluscum contagiosum traitée par sulfanilinamidothiazol et podophylline. Arch, beiges Derm. 7, 162 (1951).Google Scholar
  11. Curtin, B. J., and F.H. Theodore: Ocular molluscum contagiosum. Amer. J. Ophthal. 39, 302 (1955).PubMedGoogle Scholar
  12. Dougherty, J.: Aureomycin therapy in dermatoses of viral etiology. N.Y. St. J. Med. 51, 1932 (1951).Google Scholar
  13. Dourmashkin, R., and W. Bernhard: A study with the electron microscope of the skin tumour of molluscum contagiosum. J. Ultrastruct. Res. 3, 11 (1959).PubMedGoogle Scholar
  14. Dourmashkin, R., et B. Duperrat: Observation au microscope électronique du virus du “Molluscum contagiosum”. C.R. Acad. Sci. (Paris) 246, 3133 (1958).Google Scholar
  15. Dourmashkin, R., et H.L. Fevre: Culture in vitro sur des cellules de la souche HeLa et identification au microscope électronique du virus du Molluscum contagiosum. C.R. Acad. Sci. (Paris) 246, 2308 (1958).Google Scholar
  16. Eberl-Rothe, G., u. M. Kaiser: Über die histologischen und mikrobiellen Komponenten des Molluscum contagiosum. Arch. klin. exp. Derm. 204, 309 (1957).PubMedGoogle Scholar
  17. Ebert, M.H., and M. Otsuka: Virus diseases of the skin, with special reference to elementary and inclusion bodies. Variola-vaccinia and molluscum contagiosum. Arch. Derm. Syph. (Chic.) 48, 635 (1943).Google Scholar
  18. Epstein, W.L., M.A. Conant, and H. Krasnobrod: Molluscum contagiosum: Normal and Virus infected Epidermal Cell Kinetics. J. invest. Derm. 46, 91–103 (1966).PubMedGoogle Scholar
  19. Epstein, W.L., I. Senecal, H. Krasnobrod, and A.M. Massing: Viral antigens in human epidermal tumors: localization of an antigen to molluscum contagiosum. J. invest. Derm. 40, 51–59 (1963).Google Scholar
  20. Ferreira-Marques, J., and A. Tanissa: Epidemic of molluscum contagiosum in an orphanage. Gaz. méd. port. 7, 731 (1954).Google Scholar
  21. Ferreira-Marques, J., and A. Tanissa: Ref. Excerpta med. (Amst.), Sect. XIII 10, 23 (1956).Google Scholar
  22. Finney, R.: The treatment of the mollusca contagiosa. Lancet 1954, 862.Google Scholar
  23. Funt, T.R.: Cantharidin treatment of molluscum contagiosum. Arch. Derm. (Chic.) 83, 504–505 (1961).Google Scholar
  24. Gans, O.: Histologie der Hautkrankheiten, Bd. 2. Berlin: Springer 1928.Google Scholar
  25. Gay-Prieto, J., A.P. Rodriguez, and G. Jaqueti: Contribution to the morphogenetic and histochemical knowledge on the “molluscum contagiosum”. Acta derm.-venereol. (Stockh.). 37, 231 (1957).Google Scholar
  26. Glazunov, M.F.: Changes simulating molluscum contagiosum in the epidermis of keratoacanthoma and of some papillary neoplasms of the lower lip and skin. Vop. Onkol. 8 (6), 48–55 (1962).Google Scholar
  27. Goodpasture, E.W., and H. King: A cytologic study of molluscum contagiosum. Amer. J. Path. 3, 385 (1927).PubMedGoogle Scholar
  28. Goodpasture, E.W., and C.E. Woodruff: A comparison of the inclusion bodies of fowl pox and molluscum contagiosum. Amer. J. Path. 7, 1 (1931).PubMedGoogle Scholar
  29. Gudgel, E.F.: Can molluscum contagiosum be a venereal disease? U.S. armed Forces med. J. 5, 1207 (1954).PubMedGoogle Scholar
  30. Guy, W.H., F.M. Jacob, and W.B. Guy: Aureomycin in molluscum contagiosum. Arch. Derm. Syph. (Chic.) 60, 629 (1949).Google Scholar
  31. Hauss, H.: Molluscum contagiosum. Z. Haut- u. Geschl.-Kr. 32, I-IV (1962).Google Scholar
  32. Hill, W.R., and J.G. Downing: Molluscum contagiosum cured with Sulfapyridine. Arch. Derm. Syph. (Chic.) 46, 139 (1942).Google Scholar
  33. Hill, W.R., and S.J. Messina: Molluscum contagiosum of the capilitium. Report of two cases. Arch. Derm. Syph. (Chic.) 60, 633 (1949).Google Scholar
  34. Hövelborn, K.: Mollusca contagiosa, geheilt mit Grenzstrahlen. Zbl. Haut- u. Geschl.-Kr. 52, 199 (1936).Google Scholar
  35. Hofmann, H.: Die Viruserkrankungen der Bindehaut und Hornhaut und ihre Behandlung. Wien. klin. Wschr. 1958, 1020.Google Scholar
  36. Hung, T., and N. Draganescu: Experimental studies on molluscum contagiosum. Stud. Cercet. Inframicrobiol. 293–299 (1960).Google Scholar
  37. Imai, R.: Molluscum contagiosum and conjunctivitis. Chuo-Ganka-Iho 26, 1 (1934).Google Scholar
  38. Imai, R.: Ref. Zbl. Haut- u. Geschl.-Kr. 49, 353 (1935).Google Scholar
  39. Julianelle, L.A., and W.M. James: Molluscum contagiosum of the eye, its clinical course and transmissibility and the cultivating of the virus. Amer. J. Ophthal. 26, 565 (1943).Google Scholar
  40. Lehmann, F.: Endemisches Auftreten von Mollusca contagiosa. Z. Haut- u. Geschl.-Kr. 15, 224 (1953).Google Scholar
  41. Lipschütz, B.: Weitere Beiträge zur Kenntnis des Molluscum contagiosum. Arch. Derm. Syph. (Berl.) 107, 387 (1911).Google Scholar
  42. — Molluscum contagiosum. In: Handbuch der Haut- u. Geschl.-Kr., hgg. von J. Jadassohn, Bd. XII, Teil 3, S. 1–32. Berlin: Springer 1933.Google Scholar
  43. Marchionini, A., u. Th. Nasemann: Zur Diagnostik der durch Viren der Pockengruppe hervorgerufenen Erkrankungen des Menschen. Arch. klin. exp. Derm. 202, 69 (1955).PubMedGoogle Scholar
  44. Maruoka, T.: Statistische Beobachtungen am Molluscum contagiosum. Jap. J. Derm. 39, 91 (1936).Google Scholar
  45. Maruoka, T.: Ref. Zbl. Haut- u. Geschl.-Kr. 55, 465 (1937).Google Scholar
  46. Mathur, S.P.: Ocular complications in molluscum contagiosum. Brit. J. Ophthal. 44, 572–573 (1960).PubMedGoogle Scholar
  47. Mehregan, A.H.: Molluscum contagiosum. A clinicopathologic study. Arch. Derm. 84, 123–127 (1961).PubMedGoogle Scholar
  48. Melnick, J.L., H. Bunting, W.G. Banfield, M. J. Strauss, and W.H. Gaylord jr.: Electron microscopy of viruses of human papilloma, molluscum contagiosum, and vaccinia, including observations on the formation of virus within the cell. Ann. N.Y. Acad. Sci. 54, 1214 (1952).PubMedGoogle Scholar
  49. Mescon, H., M. Gray, and G. Moretti: Molluscum contagiosum: A histochemical study. J. invest. Derm. 23, 293 (1954).PubMedGoogle Scholar
  50. Mitchell, J. C.: Observations on the virus of molluscum contagiosum. Brit. J. exp. Path. 34, 44 (1953).PubMedGoogle Scholar
  51. Münsterer, H.O.: Virusforschung und Dermatologie. Zbl. Haut- u. Geschl.-Kr. 68, 193 (1942).Google Scholar
  52. Nasemann, Th.: Licht- und elektronenoptische Untersuchungen zur Morphologie des Molluscum contagiosum- Virus und dessen Einschlußbildungen sowie Beiträge zur Klinik, Serologie, Histopathologic u. Pathogenese des Molluscum contagiosum. I. Geschichte u. Klinik. Hautarzt 8, 301 (1957a).Google Scholar
  53. — II. Virusätiologie, Übertragungsversuche und Epidemiologie. Hautarzt 8, 352 (1957b).PubMedGoogle Scholar
  54. — Serologie, Immunitätsverhältnisse und Histologie. Hautarzt 8, 397 (1957c).PubMedGoogle Scholar
  55. — IV. Histochemie, Ultrahistologie, pathogenetische Untersuchungen u. Morphologie des Molluscum contagiosum-Virus. Hautarzt 8, 443 (1957d).PubMedGoogle Scholar
  56. — V. Mikromorphologie der Elementarkörper und der Corps ronds des Molluscum contagiosum. Hautarzt 9, 29 (1958a).PubMedGoogle Scholar
  57. — VI. Enzymatisch-morphologische Analyse des Molluscum contagiosum-Virus sowie dessen Stellung im System der Mikroorganismen. Hautarzt 9, 113 (1958b).PubMedGoogle Scholar
  58. Nasemann, Th., B. Deubner u. O. Huber: Molluscum contagiosum. Effloreszenzen, licht- und elektronenoptische Abbildungen des Molluscum contagiosum-Virus. Hautarzt 4, 341 (1953).PubMedGoogle Scholar
  59. Nasemann, Th., u. O. Huber: Elektronenoptische Untersuchungen über die Verteilung der Elementarkörpertypen nach peptischem Abbau von Molluscum contagiosum-Virus aus Effloreszenzen unterschiedlichen Alters. Z. Tropenmed. Parasit. 6, 374 (1955).Google Scholar
  60. Nasemann, Th., u. P. Stanka: Darstellung der Einschlußkörper des Molluscum contagiosum durch Pepsin-Hydrolyse und anschließende Feulgen- Reaktion. Derm. Wschr. 1959, 747.Google Scholar
  61. Nobl, G.: Experimenteller Beitrag zur Inokulationsfähigkeit des Molluscum contagiosum. Arch. Derm. Syph. (Berl.) 31, 231 (1895).Google Scholar
  62. Papoleczy, F. v.: Über Molluscum-Conjunctivitis. Klin. Mbl. Augenheilk. 91, 519 (1933).Google Scholar
  63. Payenneville, H., et A.J.P. Carteaud: A propos de Involution d’une éruption profuse de “Molluscum conta-giosum” après traitment par Ia terramycine. Bull. Soc. franç Derm. Syph. 64, 289 (1957).PubMedGoogle Scholar
  64. Peters, D., u. W. Stoeckenius: Elektronenoptische Untersuchungen über die Elementarkörper-struktur des Molluscum contagiosum-Virus. Z. Tropenmed. Parasit. 5,329 (1954).Google Scholar
  65. Pinetti, P.: Tentativi di cultura del virus del mollusco contagioso sulla membrana corio-allantoidea dell’embrione di pollo. Boll. Ist. sieroter, milan. 21, 305 (1942).Google Scholar
  66. Pinkus, H., and D. Frisch: Inflammatory reactions to molluscum contagiosum, possibly of immunologic nature. J. invest. Derm. 13, 289 (1949).PubMedGoogle Scholar
  67. Quill, T.H.: Molluscum contagiosum of eyelid and cornea. Proc. Mayo Clin. 15, 139 (1940).Google Scholar
  68. Rabito, C.: Über signifikante Erfolge mit der antibiotischen Behandlung insbesondere mit Aureomycin, beim Molluscum contagiosum. Minerva derm. 29, 94 (1954).PubMedGoogle Scholar
  69. Rabito, C.: Ref. Zbl. Haut- u. Geschl.-Kr. 88, 254 (1954).Google Scholar
  70. Rake, G., and H. Blank: The relationship of host and virus in molluscum contagiosum. J. invest. Derm. 15, 81 (1950).PubMedGoogle Scholar
  71. Raskin, J.: Molluscum contagiosum. Tissue culture and serologic study. Arch. Derm. 87, 552–559 (1963).PubMedGoogle Scholar
  72. Riggio, T.: Über die klinischen Anomalien des Mooluscum contagiosum gelegentlich eines am Nabel lokalisierten “neoplastiformen” Falles. Arch. ital. Derm. 25, 423 (1953).Google Scholar
  73. Riggio, T.: Ref. Zbl. Haut- u. Geschl.-Kr. 88, 254 (1954).Google Scholar
  74. Schiff, B.L.: Molluscum contagiosum of the buccal mucosa. A.M.A. Arch. Derm. 78, 90 (1958).PubMedGoogle Scholar
  75. Sklawunos, Th. G.: Ein Beitrag zur Histologie des Molluscum contagiosum. (Über ein solitäres exulceriertes Molluscum contagiosum der Oberlippe, ein Lippencarcinom vortäuschend.) Virchows Arch. path. Anat. 270, 70 (1928).Google Scholar
  76. Snell, E., and J.G. Fox: Molluscum contagiosum venereum. Canad. med. Ass. J. 85, 1152–1154 (1961).PubMedGoogle Scholar
  77. Spielmann, A., C. Gerard, and R. Colson: Apropos of 2 cases of molluscum contagiosum. Bull. Soc. Ophthal. (Paris) 1, 49–50 (1961).Google Scholar
  78. Tanissa, A.: Molluscum contagiosum der behaarten Kopfhaut. Gaz. méd. port. 3, 394 (1950).PubMedGoogle Scholar
  79. Tanissa, A.: Ref. Zbl. Haut- u. Geschl.-Kr. 78, 55 (1952).Google Scholar
  80. — 62 Fälle von Molluscum contagiosum in einem Internat. Therapieversuch mit Sulfonamiden, Podophyllin und Aureomycin. Gaz. méd. port. 4, 77 (1951).PubMedGoogle Scholar
  81. Tanissa, A.: Ref. Zbl. Haut- u. Geschl.-Kr. 79, 246 (1952).Google Scholar
  82. Torfs, M.: Considerations on Molluscum contagiosum in tropical milieu. Ann. Soc. beige Méd. trop. 39, 703–709 (1959).Google Scholar
  83. Tzanck, A., E. Sidi, et G.R. Melki: Trois cas de molluscum contagiosum unique, avec réaction ganglionnaire importante. Bull. Soc. franç. Derm. Syph. 56, 342 (1949).Google Scholar
  84. Virchow, R.: Über Molluscum contagiosum. Virchows Arch, path. Anat. 33, 144 (1865).Google Scholar
  85. Wada, S.: Electron microscopie studies on the molluscum contagiosum virus. J. Virol. (Kyoto) 7, 169 (1957).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1967

Authors and Affiliations

  • Günter Stüttgen
    • 1
  1. 1.Frankfurt a. M.Deutschland

Personalised recommendations